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ABSTRACT 
OLIGOPEPTIDE-FUNCTIONALIZED GRAFT COPOLYMERS:  SYNTHESIS 
AND APPLICATIONS IN NUCLEIC ACID DELIVERY 
 
FEBRUARY 2009 
 
REBECCA BOUDREAUX BREITENKAMP, B.S., UNIVERSITY OF SOUTHERN 
MISSISSIPPI 
 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Todd S. Emrick 
 
 
Utilizing the diverse functionality of amino acids, a new class of amphiphilic graft 
copolymers has been synthesized, characterized, and explored for applications in 
biomaterials and nucleic acid delivery.  This thesis research focused on the syntheses of 
oligopeptide-functionalized polyesters and polyolefins.  Polyester functionalization was 
geared towards applications in biomaterials, tissue engineering, and drug delivery by 
incorporating sequences that promote cell-adhesion.  These polyester-graft-oligopeptide 
materials were prepared by a 1,3-Huisgen cycloaddition reaction, “click” chemistry, of an 
azide-terminated oligopeptide (prepared by Fmoc-based solid phase peptide synthesis 
(SPPS)) and alkyne-containing polyester (synthesized by ring-opening polymerization).  
Following the syntheses of these materials, they were analyzed by nuclear magnetic 
resonance (NMR) and organic gel permeation chromatography (GPC). 
The oligopeptide-functionalized polyolefins were designed for nucleic acid 
complexation, and therefore the oligopeptide sequences were intended to incorporate 
positively-charged moieties (e.g., oligolysine) for DNA and short interfering RNA 
(siRNA) complexation. These graft copolymers, prepared by SPPS followed by ring-
 vii 
opening metathesis polymerization, have highly tunable structures that enable control 
over charge density and polymer backbone rigidity.  Moreover, non-ionic hydrophilic 
grafts such as polyethylene glycol were integrated into these polyelectrolytes such that 
the charges along the polymer backbone are spaced accordingly while maintaining the 
hydrophilicity of the polymer.  While numerous applications for such charged, “bio-
tailored” materials can be envisioned, this work is geared towards positively-charged 
polyelectrolytes for their potential application in nucleic acid therapy, specifically the 
delivery of plasmid DNA and siRNA.  These graft copolymers were characterized (1H, 
13C NMR, organic and aqueous GPC), studied for their solution properties (static and 
dynamic light scattering), and investigated as polyplexes with plasmid DNA. 
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CHAPTER 1 
INTRODUCTION 
1.1 Introduction 
Polymer materials are attractive candidates for many applications due to their 
unique properties and tunability in terms of structure and function.  Synthetic polymers 
can be tailored for biological applications by controlling functionality, molecular weight, 
degradation characteristics, and physical properties (Figure 1-1).  Recognizing the value 
of synthetic polymers as therapeutics and drug delivery vehicles, Ringsdorf and 
coworkers pioneered the idea of polymer-based therapeutics over 30 years ago.1  Since 
this time, this field has expanded to include such technology platforms as polymer drugs,2 
polymer-drug conjugates,3-8 polymer micelles,9-11 and ionic multicomponent 
polyplexes.12-16  In efforts to prepare polymers for specific areas such as biomaterials, 
tissue engineering, and drug delivery, biologically-relevant moieties such as 
oligopeptides,17-20 sugars,21-23 viruses,24 and drugs1 are often introduced as functional 
initiators, end groups, or pendent side chains to enhance biocompatibility and water 
solubility and enable targeted delivery for therapeutic applications (Figure 1-1).  The 
incorporation of therapeutic moieties in polymers presents synthetic and characterization 
challenges as the physical properties of such conjugates are often atypical of traditional 
polymer materials, requiring the use and development of techniques specific for each 
type of therapeutic reagent or conjugate.  
To date, linear polymers have been most utilized in polymer therapeutics due to 
the relative ease of synthesis and characterization, ability to synthesize materials with low 
polydispersity by controlled polymerization techniques, and the wide range of degradable 
  2 
and non-degradable polymer backbones available.  In addition to linear polymers, 
branched polymers, graft or comb, and dendritic polymers can be used, and in many  
 
 
 
Figure 1-1. Examples of polymer architecture and conjugation for therapeutics 
 
cases are degradable.  Despite the synthetic complexity associated with preparing 
branched and dendritic polymers, they offer attractive attributes for polymer therapeutics 
  3 
including the ability to introduce extensive and diverse functionality onto a single 
polymer chain.   
To exploit the unique attributes of polymer architecture, branched structures have 
been prepared and studied as potential polymer-based therapeutics.  For example, Stiriba, 
Kautz, and Frey examined hyperbranched and linear polyglycerols, which have potential 
for therapeutic delivery applications as nanocapsules.25  Unlike their linear analogs, 
hyperbranched polyglycerols were able to encapsulate hydrophilic, small molecule dyes, 
illustrating the benefit of macromolecular architecture for encapsulation/delivery 
applications. 
Dendritic macromolecules are perfectly-branched structures that have been 
designed recently for in vivo applications such as drug delivery and magnetic resonance 
imaging (MRI) contrast agents.  During the early 1990’s, Newkome et al. synthesized 
unimolecular micelles consisting of an amphiphilic dendrimer with a hydrophobic 
interior and hydrophilic periphery.26  Due to the interior hydrophobic cavity, these 
materials offered the potential to encapsulate hydrophobic, small-molecule drugs.  
Fréchet and coworkers have also evaluated a variety of dendrimers and dendritic-like 
macromolecules for applications in drug delivery.  Taking advantage of the unique 
structure and properties of dendrimers, degradable polyester-based systems,27 pH-
responsive assemblies,28,29 dendrimer-drug conjugates,30 small molecule and protein drug 
delivery agents,28,31-33 and targeted delivery systems30 have all been synthesized based on 
these three-dimensional branched structures. 
The use of dendrimers as MRI contrast agents has also been explored, beginning 
with the work of Wiener, Tomalia, and coworkers.34  These contrast agents consist of 
  4 
amine-functionalized PAMAM dendrimers conjugated to chelator moieties, enabling the 
binding of gadolinium ions.  The ability to attach numerous chelating moieties to the 
dendrimer periphery is advantageous for imaging.  Some dendrimer-metal chelate 
conjugates bind up to 170 gadolinium ions, far exceeding the degree of functionalization 
possible in linear polymer systems, where steric crowding limits the extent of chelation 
possible.  
While dendrimers offer promise for a variety of therapeutics, questions 
concerning their cytotoxicity and scalability due to their multi-step synthesis have to date 
limited their commercialization.35  In this thesis work, efforts are made to integrate the 
advantages of branching through graft copolymer architectures, prepared by simple, 
conventional polymerization methods.  Specific graft copolymer targets include aliphatic 
polyesters, which are hydrolytically degradable, and hydrophilic polyolefins, which are 
hydrolytically stable.  Both types of materials carry potential in therapeutic applications, 
which will be introduced below and described specifically in subsequent chapters.   
1.2 Polyesters for Therapeutics   
The synthesis of polymers containing biologically active groups has been 
undertaken with a variety of polymer structures including polyesters, polyanhydrides, 
polyethers, and polymethyl(acrylates) as the backbone structure.  Langer and coworkers 
have studied degradable polymers as scaffolds for polymer-drug conjugates,36 delivery of 
protein and DNA drugs,37-40 targeted therapeutics,19 and tissue engineering.19  Recently, 
polymer-drug conjugates were prepared from commercially available dextran, a 
biodegradable, biocompatible material, by its covalent conjugation to the chemotherapy 
drug methoxtrexate.  The polymer and drug were linked by an enzyme-specific 
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oligopeptide sequence,36 Pro-Val-Gly-Leu-Ile-Gly, which is cleaved selectively by matrix 
metalloproteinases, zinc-dependent enzymes found in elevated levels in cancerous tissue.  
This design enables the site-specific enzymatic cleavage and release of the active drug. 36  
These conjugates showed promise as an improved treatment method by offering 
increased solubility and stability over the free drug and are currently under investigation 
to determine in vivo stability and efficacy. 
Other efforts in polymer therapeutics center on the development of biocompatible 
polymer materials for tissue engineering applications.19,20,41  These systems utilize 
degradable polymers that often incorporate oligopeptide sequences and hydrophilic 
groups provide biocompatibility, water solubility, and receptor-ligand interactions.  For 
example, Hubbell and coworkers synthesized a cross-linked poly(ethylene glycol)-co-
poly(acrylic acid) network that was functionalized subsequently with RGD-containing 
peptide sequences through the carboxylic acids in the poly(acrylic acid) block to promote 
polymer-cell adhesion.41  In addition, Langer and coworkers have reported the pendent 
functionalization of poly(lactic acid-co-lysine) with the adhesion-promoting sequence 
RGD for material applications where cell growth is desired (e.g., tissue engineering).  
This was accomplished by ring-opening polymerization of a lactone with a protected 
lysine side chain, which was then deprotected to give free primary amines.19  The acid 
terminus of the RGD-containing oligopeptide was coupled to this amine on the polyester 
to generate pendent, oligopeptide functionality.  Despite the progress this work 
exemplified in the incorporation of oligopeptides into a hydrolytically degradable system, 
problems encountered using this methodology included crosslinking, low peptide 
incorporation (less than 1 mole percent), and polyester backbone degradation.  Such 
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issues underscore the need for compatibility between the backbone structure and 
functionalization conditions. 
1.3 Polyolefins in Biomaterial Applications  
Polyolefins such as polyethylene and polypropylene are classic commercial 
plastics not often viewed as biologically relevant.  However, polyolefins have been 
explored in biological applications with their hydrolytically stable properties making 
them suitable as implants and structured materials.42-44  Due to its functional group 
tolerance,45,46 modern metathesis chemistry has enabled the synthesis of wide variety of 
polyolefins including those with pendent carboxylate,47 ammonium,48 and oligopeptide49-
51 groups.  For example, as shown in Figure 1-2, acyclic diene metathesis (ADMET) has 
been used to incorporate single amino acids, peptide dimers, or trimers into unsaturated 
hydrocarbon polymer backbones.  Hopkins and Wagener described the integration of 
various amino acids into these polyolefins using acyclic diene monomers and Grubbs’ 
Generation II catalyst.  The resulting semi-crystalline material exhibited changes in its 
melting temperature due to the incorporation of these amino acid moieties.49,52-54 
Using ring-opening metathesis polymerization (ROMP), Grubbs, et al. prepared 
polyethers with phenylalanine groups55 and poly(norbornene)s with bioactive moieties 
such as GRGDS and PHSRN to synergistically inhibit cell binding to fibronectin-coated 
surfaces to demonstrate the bioactivity of these oligopeptide-functionalized polymers.50,51  
In the polynorbornene examples (Figure 1-2), a variety of monomers were prepared and 
functionalized with individual amino acids or oligopeptide sequences and then 
polymerized using Ru-based ROMP.  Homopolymers of these monomers were prepared 
as well as copolymers with short PEG chains.  The resulting GRGDS and PHSRN 
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materials were found to substantially reduce cell adhesion to fibronectin-coated surfaces 
due to the ligand-based polymer-cell interactions, demonstrating the promise of ROMP-
derived materials for biological applications. 
 
Figure 1-2. Application of metathesis techniques to synthesize bio-tailored 
polyolefins 
 
ROMP has also been used to incorporate other biomolecules, such as sugars, into 
polyolefins.  Grubbs and Fraser reported well-controlled, low polydispersity 
polynorbornenes with two sugar groups per repeat unit, illustrating the functional group 
tolerance of these ruthenium catalysts and enabling the synthesis of polyolefins with 
highly-functional side chains.22  Kiessling and coworkers have also prepared saccharide-
containing polynorbornenes to prepare polyvalent scaffolds capable of protein 
recognition.21,23  These polymers demonstrated both binding efficiency and recognition 
specificity in their ligand interactions with the mannose/glucose-binding protein 
concanavalin A, resulting in their potent inhibition of cell agglutination (i.e., the 
aggregation of cells as a result of the protein agglutinin on the cell surface).  The 
multivalent nature of these polymers provides superior activity relative to the monovalent 
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sugar derivatives.  One polynorbornene-mannose derivative exhibited a 50,000-fold 
increase in inhibitory activity.23 
1.4 Polymers for Nucleic Acid Delivery  
Synthetic, cationic polymers have emerged as reagents for complexation of 
plasmid DNA (pDNA) and short interfering RNA (siRNA), termed polyplexes.  Because 
of the potential beneficial, medical impact of effective nucleic acid delivery, numerous 
research labs have pursued this topic over the past 15-20 years.21  Science magazine’s 
scientific breakthrough of 2002 was the RNA interference (RNAi) process, promoting 
these small RNAs as having the potential to revolutionize modern medicine.56  RNAi is 
the process by which short, single-stranded RNA (20-22 bases in length) binds messenger 
RNA (mRNA) in the cytoplasm, marking the mRNA for destruction and therefore 
preventing its protein expression.  This process can be used to knockdown specific genes 
to better determine their role or function in the cell.  On the therapeutic side, small RNAs, 
also known as short interfering RNA (siRNA), have been shown to shut down diseased 
cells for cancer and HIV in vitro.57-59  Shortly after their discovery of the RNAi process, 
Mello and Fire were awarded the 2006 Nobel Prize in Medicine.  However, despite the 
magnitude of the accomplishment, practical therapeutic applications for siRNA have 
been slowed by ineffective delivery methods.  Improving the delivery of these short 
nucleic acids will enable progress toward clinical use of RNA treatments for cancer, HIV, 
and other diseases.  Indeed delivery is at the core of siRNA therapy and other nucleic 
acid treatments, making it imperative the development of new materials that can safely 
deliver these reagents to the desired in vivo target(s).   
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An ideal nucleic acid delivery system would encapsulate the desired nucleic acid, 
deliver it only to diseased cells, and efficiently express of the encapsulated nucleic acid 
(in plasmid DNA therapy) or shutdown the complementary mRNA (in siRNA therapy) 
while remaining non-immunogenic and non-cytotoxic throughout the body.  While the 
goal of gene therapy is to transport the genetic material to the nucleus where it can be 
expressed, siRNA therapy focuses on the shutdown of diseased genes.  The goal of 
delivering siRNA is to transfect this 20-22 base pair oligonucleotide sequence to the 
cell’s cytoplasm, where it will bind with complimentary mRNA, marking it for 
destruction and preventing the mRNA from producing the undesired proteins associated 
with the disease.60,61   
 
 
Figure 1-3. Ideal nucleic acid delivery system 
 
Currently, the primary approach to nucleic acid condensation and delivery uses 
viral vectors.  Genetically-modified viruses, such as adenoviruses and retroviruses, 
provide excellent transfection efficiencies and subsequent gene expression.  However, 
serious safety issues, including the onset of leukemia-like symptoms and patient death in 
clinical trials,62,63 have called into question the clinical viability of this approach.  Non-
viral approaches to gene therapy are gaining momentum especially using cationic 
liposomes, small molecule and polymer-DNA conjugates, and polymer micelles for the 
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condensation or packaging of genetic material.  Despite their reduced transfection 
abilities, non-viral systems exhibit fewer safety issues and can be better tailored for the 
desired application.  Synthetic polymers, in particular, offer modularity in synthetic 
design with the ability to control molecular weight, polymer backbone, degradation 
abilities, and incorporation of targeting moieties and other functionalities. 
The complexation of DNA with cationic materials such as polylysine and 
polyarginine have been studied for over 40 years.64,65  In 1995, Boussif and coworkers 
first introduced poly(ethylene imine) (PEI), a common polymer for industrial 
applications, as a cell transfection agent.66  PEI displays superior transfection efficiency 
to other polymer-based systems and is considered to be state-of-the-art polymer 
transfection reagent, available commercially under trade names such as JetPEI (PolyPlus 
Transfection, Inc.).  PEI’s excellent transfection efficiency is attributed to its ability to 
effectively escape the endosome due to its proton sponge-like abilities of its backbone 
secondary amines, i.e., the capability of the molecule to act as a reservoir for protons.  
However, due to its cationic nature, PEI is cytotoxic.   
While most research efforts focus on the modification of commercially-available 
polymers to improve nucleic acid delivery, several research groups have designed 
structurally-unique polymer transfection reagents (Figure 1-4), providing insight on the 
structural parameters that facilitate effective cell transfection and DNA expression.  The 
design of synthetic polymers for effective and safe transfection can benefit from 
consideration of both macromolecular architecture and functionality.  DNA binding 
affinity, ability to aid in endosomal escape, and biocompatibility are key features in 
transfection that can be addressed by synthetic vectors.  The binding affinity of DNA to 
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cationic polymers is important as premature dissociation reduces cellular entry or leads to 
nucleic acid degradation in the extracellular environment or in the endosome.  
Kataoka and coworkers have designed an array of polymeric transfection reagents 
over the past ten years with recent efforts based on functionalized PEG-block-poly(amino 
acid) structures (Figure 1-4).12,14  In one example, thiol moieties were incorporated to 
enable reversible crosslinking while controlling charge density.14  Such a system was 
designed to create stable crosslinked structures, encapsulating and protecting pDNA 
while circulating in vivo and later releasing DNA upon entry into the intracellular 
cytoplasm.  This release is triggered by the presence of excess glutathione, a reducing 
agent found in large quantities in the cytoplasm as compared to other areas of the body.  
These studies found that the polymers yielding the highest protein expression balanced 
charge density and stability via disulfide crosslinking (i.e., if the degree of crosslinking 
was too high, decreased protein expression was observed).  The structure of the most 
effective, environmentally-sensitive transfection reagent in these studies is shown in 
Figure 1-4.  The crosslinking also improved the shelf-stability of these materials, which 
is important for commercial applications, and enabled the complexes to undergo freeze-
thaw cycles without compromising their transfection abilities.  However, these 
polyplexes only exhibited moderate protein expression and would need structural 
modifications to improve cell transfection and subsequent protein expression. 
Kataoka et al. also prepared polymers with similar backbones for the 
encapsulation and delivery of siRNA.12  As shown in Figure 1-4, the block copolymer 
incorporated both primary and secondary amines into the side chains to allow ionic 
complexation with the nucleic acid (primary amines) and to enhance the endosomal 
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buffering capacity (secondary amines).  These polycations were found to be more 
effective than PEG-block-polylysine and comparable to RNAiFect, a commercial, lipid-
based material from Qiagen, at knockdown of the targeted protein expression.  However, 
in contrast to RNAiFect, these materials were stable in the presence of serum, showing no 
change in the subsequent knockdown efficiency, and still maintained greater than 75% 
cell viability.  
 
Figure 1-4. Polymer-based transfection agents for siRNA and/or pDNA delivery 
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Reineke, Liu, and coworkers have focused on creating new polymer transfection 
reagents by combining PEI-like segments with various biocompatible functionalities such 
as saccharide moieties.  In an effort to combine the effective cell transfection and 
expression of PEI and the biocompatibility of chitosan, a new library of 
poly(glycoamidoamine) materials (Figure 1-4) was synthesized with varying length 
oligoamine segments and hydroxyl group stereochemistry.67,68  These polymers were able 
to maintain the biocompatibility as reflected in high cell viability typical of chitosan-
based reagents while, in some cases, also achieving high cell transfection relative to PEI.  
It was also found that increased binding efficiency between the polycation and DNA, 
which was correlated to the length of the oligoamine moiety in this case, resulted in more 
effective cell transfection and DNA expression. 
Building upon this work, the Reineke group recently used click chemistry to 
synthesize poly(glycoamidoamine)s with higher molecular weights than obtained by 
other condensation-based polymerization methods.69   Higher molecular weight polymers 
have been shown to create more stable polyplexes with DNA and therefore are desirable 
as polymeric transfection reagents.70-72  This synthetic methodology also allowed the 
introduction of triazole groups, which like pyrrole or imidizole-containing polymers,73 
bind with DNA in a specific manner (via hydrogen bonding to the DNA base pairs) to 
increase complex stability.  Other structural components were also included to enhance 
this transfection reagent including trehalose groups, which are known to enhance 
biocompatibility and prevent protein adsorption, and PEI-like oligoamine segments to 
promote electrostatic binding to DNA and aid in endosomal escape.  The resulting 
polymers were found to be stable in water, serum, and salt, able to transfect cells in the 
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presence and absence of serum, and maintain high cell viability with respect to the 
commercial reagent JetPEI.  By changing the polymer structure, it was found that the 
properties of polycation-DNA complexes were governed by a combination of polymer 
backbone stiffness, electrostatic interactions, and hydrogen bonding interactions.  
However, these polymers still did not achieve protein expression levels as found in lipid-
based, commercial transfection reagents such as Invitrogen’s Lipofectamine 2000. 
Our research efforts focused on preparing novel, tailored polymers for various 
biological applications based on a modular synthetic pathway.  Amphiphilic graft 
copolymers were chosen for this research for their tunability and the ability to incorporate 
a wide range of functionality (e.g., oligopeptides, PEG, and reactive groups) into the 
backbone.  This modularity enables control over factors such as charge density, 
hydrophilicity, and size, all of which are critical characteristics of polymers used in 
nucleic acid delivery.  
1.5 Research Outlook   
This thesis research focused on the syntheses of oligopeptide-functionalized 
polyesters and polyolefins (Figure 1-5).  Polyester functionalization was geared towards 
applications in biomaterials, tissue engineering, and drug delivery by incorporating 
sequences that promote cell-adhesion (Chapter 2).  These polyester-graft-oligopeptide 
materials were prepared by a 1,3-Huisgen cycloaddition reaction, “click” chemistry, of an 
azide-terminated oligopeptide (prepared by Fmoc-based solid phase peptide synthesis 
(SPPS)) and alkyne-containing polyester (synthesized by ring-opening polymerization).  
Following the syntheses of these materials, they were analyzed by nuclear magnetic 
resonance (NMR) and organic gel permeation chromatography (GPC). 
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Figure 1-5. Oligopeptide-functionalized polyesters and polyolefins for biomaterials 
and nucleic acid delivery applications 
 
The oligopeptide-functionalized polyolefins are described in Chapters 3 and 4.  
These polymers were designed for nucleic acid complexation, and therefore the 
oligopeptide sequences are intended to incorporate positively-charged moieties (e.g., 
oligolysine) for DNA and siRNA complexation.  Due to the modularity of the synthetic 
procedure, these polymers will also be explored as a new general class of polyelectrolyte 
materials incorporating other charged amino acids into the polymer chain and observing 
their solution properties (Chapter 3).  SPPS was used to prepare the requisite 
macromonomer, and ROMP was utilized to prepare these oligopeptide-functionalized 
polymers.  These graft copolymers were then characterized (1H, 13C NMR, organic and 
aqueous GPC) and studied to determine their unique solution properties (static and 
dynamic light scattering) and their potential as DNA delivery vectors. 
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CHAPTER 2 
OLIGOPEPTIDE-FUNCTIONALIZED POLYESTERS 
2.1 Functionalization of Polyesters   
Incorporating functional groups into aliphatic polyesters represents a synthetic 
challenge due to the inherent hydrolytic sensitivity of esters.  Commercially-available 
aliphatic polyesters are not suited for all desired polyester applications, thus numerous 
efforts have been made to modify their structure to enhance water-solubility and cell 
targeting.1-3  Conditions for polyester functionalization must be carefully chosen to 
prevent backbone degradation.  Oligopeptide-incorporation into aliphatic polyester is 
particularly difficult, as state-of-the-art oligopeptide synthesis uses coupling and 
protection/deprotection conditions that are incompatible with the polyester backbone.  
Another approach is to conjugate a deprotected oligopeptide with a functionalized 
polyester.  However, deprotection prior to coupling presents problems associated with 
oligopeptide functionality (i.e., amines, alcohols, and carboxylic acids) that can interfere 
with the intended grafting.  In light of these problems, most attempts to decorate aliphatic 
polyesters with peptide sequences have involved end-group functionalization or use of 
functional initiators.  To our knowledge, only one example of the synthesis of a 
polyester-graft-oligopeptide was reported prior to this thesis research.  This work was 
from Langer and coworkers who polymerized a cyclic dimer of L-lactic acid and 
protected L-lysine by ring-opening polymerization followed by deprotection of the 
primary amines (Figure 2-1).1  The C-terminus of an RGD-containing oligopeptide was 
then coupled to the pendent amine groups.  Using this methodology, a small degree (less 
than 1 mole percent) of oligopeptide incorporation was achieved, but problems such as 
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crosslinking and backbone degradation were also encountered as would be expected from 
the reaction of the two multifunctional reagents. 
 
Figure 2-1. Synthesis of oligopeptide-functionalized polyesters by Langer and 
coworkers  
 
 
In order to address these issues, we wanted to examine whether the mild reaction 
conditions associated with the Huisgen 1,3-dipolar cycloaddition of azides and alkynes, 
an example of a “click” reaction, were applicable to aliphatic polyesters.4,5  Click-
cycloaddition has recently gained popularity due to its high degree of specificity, 
functional group tolerance, and ability to proceed in either aqueous or organic solvents.  
This triazole formation is particularly attractive due to the ease with which these 
functional groups can be introduced into small molecules and polymers.  Sharpless, 
Fokin, Finn, and coworkers have reported extensively on these reactions, and they along 
with others have applied click chemistry to small molecules,4,5 virus particles,6 cell 
membranes,7 dendrimers,8,9 and other polymers10 (Figure 2-2).  In this research, the 
question of whether click chemistry could be applied to polyesters and enable the 
incorporation of oligopeptide sequences without polymer degradation was investigated.  
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Specifically, Cu(I)-catalyzed click chemistry was applied for grafting oligopeptides to 
alkyne-functionalized aliphatic polyesters.  This method enables the “bio-tailoring” of 
aliphatic polyesters, structures already of interest in biomaterials research but potentially 
enhanced for tissue engineering and drug delivery by attaching oligopeptides. 
 
 
 
Figure 2-2. Synthesis and functionalization of materials using click chemistry 
  23 
2.2 Results and Discussion  
Aliphatic polyesters containing pendent alkynes were prepared as shown in 
Figure 2-3 by Bryan Parrish (Emrick Research Group, Ph.D. 2006).11  ?-Propargyl-?-
valerolactone 1, synthesized from ?-valerolactone and propargyl bromide, was then 
polymerized by Sn(OTf)2-mediated ring-opening polymerization.  The alkyne-containing 
lactone could be copolymerized with ?-caprolactone 2 or homopolymerized 3 in a 
controlled fashion, yielding aliphatic polyesters with molecular weights typically ranging 
from 6,000 – 16,000 g/mol with polydispersities between 1.1 – 1.2.  
 
Figure 2-3. Synthesis of alkyne-functionalized polyesters 
 
Due to its known cell binding properties,12,13 a RGD-containing sequence was 
selected as the oligopeptide target.  In this research, an azide-functionalized oligopeptide 
4 was prepared by Fmoc-based solid phase peptide synthesis (Figure 2-4), starting from a 
serine-loaded Wang resin and using the peptide coupling agent O-(Benzotriazol-1-yl)-
N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU).14  The oligopeptide 
sequence was end-capped with 6-bromohexanoic acid under carbodiimide coupling 
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conditions (DIC, HOBt, DMF) and cleaved from the resin with a 95:2.5:2.5 mixture of 
TFA:water:triisopropylsilane (TIPS).15   
In the published synthesis11, conversion of the oligopeptide-bromide to 
oligopeptide-azide was carried out following cleavage from the resin.  This was achieved 
using excess sodium azide in DMSO at room temperature for three hours.  The DMSO 
was removed, and the oligopeptide was purified by precipitation and characterized by 
NMR, IR, and mass spectrometry.   
Some problems (e.g., residual DMSO) associated with this method led to a search 
for improved conditions.  An on-resin azide functionalization was tried following the 
addition of 6-bromohexanoic acid and prior to resin cleavage.  Excess NaN3 in 85:15 
DMF:MeOH was added to the resin, and the mixture was agitated for three hours.  After 
this time period, it was found that the bromide to azide conversion went only to 75% 
completion based on 1H NMR spectroscopy (Br ?-protons – triplet at 3.52 ppm, N3 ?-
protons – triplet at 3.32 ppm).  Therefore, the resin was filtered, and fresh NaN3 solution 
was added to the resin.  After three hours of agitation, complete conversion to the desired 
azide group was observed by NMR.   The SDGRG-N3 5 sequence was then deprotected 
and cleaved from the resin with 95:2.5:2.5 TFA:water:TIPS and purified by precipitation 
in diethyl ether.  The desired compound was isolated as a white solid in 99% yield (based 
on resin loading) and characterized by 1H and 13C NMR, IR, and low and high resolution 
mass spectrometry, all of which supported the desired structure.  High resolution mass 
spectrometry (HRMS-FAB) yielded a major [M+H]+ peak at 630.296, the exact value of 
the calculated mass, and the diagnostic azide stretch was observed by IR at 2097 cm-1. 
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Figure 2-4. Two methods for the Fmoc-based solid phase peptide synthesis of 
SDGRG-azide 5 
 
 
 After synthesizing both the alkyne-containing polyesters 2 and 3 and azide-
capped oligopeptide 5, the Cu(I)-catalyzed click reaction was used to prepare the desired 
oligopeptide-functionalized polyester (Figure 2-5).11  Initial attempts to synthesize 
aliphatic polyester-graft-oligopeptides were carried out on the alkyne-functionalized 
homopolymer 3 to give 5 mole percent peptide grafting.  To achieve this, compound 5 
(0.05 eq) was dissolved in water, and an acetone solution of the alkyne-polyester 
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homopolymer 3 (1.0 eq) was added drop wise to the aqueous, rapidly stirring, peptide 
solution.  Copper sulfate pentahydrate (0.4 eq) and sodium ascorbate (0.8 eq) were 
introduced into the solution, and the mixture was heated to 100 ºC for three hours and 
stirred overnight at 80 ºC.  The solution was cooled to room temperature and diluted with 
an aqueous saturated NaCl solution.  The product was extracted with methylene chloride, 
dried over magnesium sulfate, and concentrated on a rotary evaporator.   
 
Figure 2-5. Synthesis of oligopeptide-grafted polyester by click chemistry 
 
The peptide-functionalized polyester 6 obtained in this fashion was characterized 
by 1H NMR spectroscopy and GPC (Figure 2-6).  The success of the reaction was 
confirmed by the presence of signals in the 1H NMR spectrum from ? 6.70-7.80 ppm, 
corresponding to the peptide amides and triazole.  It should be noted that the azide-
terminated SDGRG oligopeptide is not soluble in chloroform, and if physically mixed 
with the starting polyester, its proton signals were not observed in 1H NMR spectroscopy 
in CDCl3.  The presence of signals in the amide region of the 
1H spectrum provides 
evidence for the covalent attachment of the oligopeptides to the polyester backbone.   
To further support peptide grafting and investigate the integrity of the polyester 
backbone over time, GPC characterization in DMF was performed on the resulting 
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materials.  GPC characterization of the peptide-functionalized product (Figure 2-6) 
changed only slightly from the starting material as expected for such a low grafting 
density.  It is apparent from the GPC traces that no substantial crosslinking or 
degradation of the polyester occurred during the course of the reaction.  Moreover, it 
appears that these polyesters are shelf stable.  The weak signal at low retention time (high 
molecular weight) in the GPC trace is attributed to possible aggregation of the 
oligopeptide-functionalized aliphatic polyester in the eluent (DMF). 
 
Figure 2-6. GPC characterization of the starting polyester 3 (left) and the polyester-
graft-oligopeptide 6 (right) after the click reaction 
 
 In summary, a new synthesis has been presented in which aliphatic polyesters are 
functionalized with oligopeptides.  The synthesis relies on polymerization of alkyne-
functionalized lactones and subsequent grafting using click cycloaddition of azide-
terminated oligopeptides.  This approach represents a convenient, rapid, and versatile 
synthesis of functionalized aliphatic polyesters, in which the mild conditions associated 
with click chemistry allow for post-polymerization functionalization in the absence of 
polyester degradation.  It is anticipated that the structural and functional variation 
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obtained by the methods outlined here will useful in several areas, including biomaterials 
and various encapsulation and delivery technologies. 
2.3 Future Research   
Future efforts on the optimization of the reaction conditions with respect to 
temperature and catalyst selection could provide valuable insight of the scope of this 
click methodology for polyesters.  It was postulated that the high reaction temperature 
(100 ºC) needed for cycloaddition onto polyester backbone (many click reactions proceed 
rapidly at room temperature) was due to binding of the copper to the wide range of 
functionality in the oligopeptide side chains.  In fact, binding of Cu(II) with peptide 
amides has been reported16 and may be the reason higher temperatures were required.  
Different copper-based catalyst systems have been developed for the optimization of 
click chemistry and involve the addition of various ligands and reducing agents.  One 
useful system employs copper sulfate in conjunction with the ligand 
bathocuproinedisulphonic acid disodium salt hydrate and the reducing agent tris(2-
carboxyethyl)phosphine hydrochloride.17,18  The system may reduce Cu(II)-peptide 
interactions due to ligand binding and facilitate the click reaction of the SDGRG 
sequence at lower temperatures. 
Demonstrating versatility with respect to percent peptide incorporation and the 
oligopeptide sequence would also being interesting in further studies.  Initial efforts 
focused on incorporating only five mole percent oligopeptide so as to maintain the 
organic solubility of the polymer and facilitate isolation and characterization.  However, 
higher levels of oligopeptide may be desirable in certain applications.  Also, 
demonstrating versatility of this methodology in terms of the selected oligopeptide 
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sequence is important.  Many azide-terminated oligopeptides are in principle suitable for 
click chemistry.  One proposed study would focus on clicking cationic oligopeptides to 
aliphatic polyesters for applications in nucleic acid encapsulation and delivery.  While the 
polyolefin-graft-pentalysine system offers a hydrolytically stable, robust backbone that 
can be used to encapsulate plasmid DNA as discussed in Chapters 3-4, a polyester-graft-
pentalysine (or other cationic amino acid) generates a polymeric encapsulation system 
that is degradable.  Azide-functionalized pentalysine and pentaarginine sequences have 
been prepared by solid phase peptide synthesis as previously described for SDGRG.  In a 
similar approach to the polyolefin system described in Chapters 3-4, variations in the 
polymer structure could be explored for such applications including the incorporation of 
other cationic sequences (lysine versus arginine) and PEG groups in conjunction with the 
peptide grafts.  
2.4 Experimental Section?
2.4.1 Materials  
1-hydroxybenzotriazole (HOBt) (<5% water), piperidine (99+%), N,N'-
diisopropylcarbodiimide (DIC) (99%), 2,2,2-trifluoroethanol (TFE) (99.5%), 6-
bromohexanoic acid (98%), sodium azide (99.5%), TIPS (99%), and phenol (99+%) were 
purchased from Sigma Aldrich (Saint Louis, MO).  N,N-diisopropylethylamine (DIPEA) 
(99%) was obtained from Alfa Aesar (West Chester, PA).  Copper (II) sulfate 
pentahydrate (ACS reagent grade) and TFA (reagent grade) were purchased from Thermo 
Fisher Scientific Inc. (Waltham, MA).  Fmoc-Gly-OH, Fmoc-Ser(But)-OH, Fmoc-
Asp(OBut)-OH, Fmoc-Arg(Pbf)-OH, HBTU, and Fmoc-Ser(But)-loaded Wang resin 
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(100-200 mesh, loading density of 0.6 mmol/g) were purchased from Advanced 
ChemTech (Louisville, KY).  Deuterated solvents CDCl3 and D2O were obtained from 
Cambridge Isotopes (Andover, MA).  Sodium ascorbate (crystalline) was purchased from 
Source Naturals.  CH2Cl2 was washed according to standard procedures
35 and distilled 
over CaH2.  All other materials were used without additional purification.  ?
2.4.2 Instrumentation   
NMR spectra were recorded in CDCl3, d6-DMSO, or D2O solutions using a 
Brüker DPX300, Brüker Avance400, or Brüker Avance600 spectrometer (w13C = 
0.25*w1H).  Molecular weights and polydispersity indices were measured by gel 
permeation chromatography in DMF relative to polystyrene standards (Scientific 
Polymer Products Mp= 503, 700, 1306, 2300, 4760, 12,400, 196,700 and 556,000 g/mol) 
on systems equipped with three-column sets (Polymer Laboratories 300 x 7.5 mm, 5 mm, 
10-5, 10-4, and 10-3 Å pore sizes) and refractive-index detectors (HP 1047A) at room 
temperature (THF) and 50 ˚C (DMF) with a flow rate of 1 mL/min.  High resolution mass 
spectral (HRMS) data were obtained on a JEOL JMS700 MStation.  IR absorbance data 
was obtained on a Perkin Elmer Spectrum One FT-IR spectrometer equipped with a 
universal ATR sampling accessory.  
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2.4.3 Synthesis of ?-Propargyl-?-valerolactone (1)   
 
n-Butyllithium (42.5 mL, 93.5 mmol) was added by syringe to a solution of N,N-
diisopropylamine (13.1 mL, 93.5 mmol) in 625 mL THF at -78 ˚C and stirred for 15 
minutes.  A solution of  ?-valerolactone (8.51 g, 85.0 mmol) in 225 mL THF was added 
drop wise over 1.5 hours and then stirred for an additional 30 minutes.  Propargyl 
bromide (11.4 mL, 102 mmol) and hexamethylphosphoramide (17.7 mL, 102 mmol) 
were added drop wise over 20 minutes.  The reaction mixture was then warmed to 
approximately -30 °C, and the temperature was maintained while stirring for two hours.  
Excess aqueous ammonium chloride was added, and the reaction mixture was allowed to 
warm to room temperature.  Volatiles were removed by rotary evaporation.  The resulting 
product was dissolved in ether, washed with a saturated NaCl aqueous solution, diluted 
with hexanes, washed again with the NaCl solution, dried over MgSO4, and concentrated.  
Column chromatography (gradient 0-30% EtOAc in hexanes) on silica gel followed by 
Kugelrohr distillation afforded 1 as a colorless, viscous liquid (8.68 g, 74% yield).  
HRMS-EI (m/z): [M+H]+ calculated for C8H11O2 139.076, found 139.078.  
1H NMR 
(CDCl3, 300 MHz):  d (CHCl3 = 7.26 ppm) 4.28 (m, 2H, CH2O), 2.62 (m, 2H, 
COCHCH2), 2.46 (m, 1H, COCHCH2), 2.22 (sxt, J = 6.4 Hz, 1H, CHCH2CH2), 1.97 (t-d, 
J = 2.7 Hz J = 1.0 Hz, 1H, C?CH), 1.89 (q, J = 6.3 Hz, 2H, CH2CH2CH2), 1.68 (m, 1H, 
COCHCH2) ppm.  
13C NMR (CDCl3, 75 MHz):  d (CHCl3 = 77.0 ppm) 172.8 (C=O), 
81.1 (C?CH), 70.4 (CH2O), 68.8 (CH?C), 38.9 (CC=O), 24.1 (CCH2CH2), 22.0 
(CCH2CH2), 20.7 (CH2C?CH) ppm.  IR(ATR): C?C-H 3280, C=O 1724 cm-1. 
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2.4.4 Representative Polymerization - Synthesis of (2)    
 
Lactone 1 and ?-caprolactone were distilled over CaH2.  Glass reaction vessels 
were flame-dried three times under a stream of N2(g).  EtOH (110 mL, 1.7 M solution in 
THF) and Sn(OTf)2 (150 mL, 3.7 x 10
-2 M solution in THF) were introduced to the 
reaction vessel and allowed to stir for 15 minutes.  Compound 1 (1.10 g, 8.0 mmol) and 
?-caprolactone (0.91 g, 8.0 mmol) were then added to the vessel by syringe.  The mixture 
was stirred at room temperature for 48 hours and then dissolved in acetone and 
precipitated into cold hexanes.  Residual 1 was removed by passage through a plug of 
silica gel, eluting with 50:50 EtOAc:hexanes followed by elution of the product with 
acetone.  Solvent was removed by rotary evaporation to give pure polymer 2 as a clear 
viscous liquid (1.83 g, 91%).  GPC (THF):  Mn = 7.5 x 10
3 g/mol, PDI = 1.11.  1H NMR 
(CDCl3, 300 MHz): ? (CHCl3 = 7.26 ppm) 4.07 (m, 4H, CH2OPVL+CL), 2.58 (m, 1H, 
C=OCHPVL), 2.45 (m, 2H, CH2C?CHPVL), 2.29 (tr, J = 7.3 Hz, 2H, C=OCH2CL), 2.03 (m, 
1H, C?CHPVL), 1.64 (br m, 8H, CH2CH2CH2OPVL + CH2CH2CH2CH2OCL), 1.39 (br m, 
2H, CH2CH2CH2OCL) ppm.  
13C NMR (CDCl3, 75 MHz):  ? (CHCl3 = 77.0 ppm) 174.1 
(C=OPVL), 173.6 (C=OCL), 81.1 (C?CHPVL), 70.2 (C?CHPVL), 64.6 (CH2OPVL), 64.2 
(CH2OCL), 44.0 (C=OCHPVL), 34.2 (C=OCH2CL), 28.4 (CH2CH2OCL), 27.6 (CHCH2PVL), 
26.2 (CHCH2CH2PVL), 25.6 (C=OCH2CH2CH2CL), 24.6 (C=OCH2CH2CL), 21.3 
(CH2C?CHPVL) ppm.  IR(ATR): C?C-H 3283, C=O 1726 cm-1. 
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2.4.5 Synthesis of Azide-terminated SDGRG (5) from Bromide-terminated SDGRG 
(4) using Method 1   
 
The oligopeptide sequence SDGRG was synthesized according to standard Fmoc 
solid phase peptide synthesis using the batch wise process and the peptide coupling agent 
HBTU.  Fmoc-Ser(But)-loaded Wang resin (3.12 g with loading density of 0.6 mmol/g) 
was weighed into an oven-dried glass-fritted reaction tube and swollen with 30 mL dry 
CH2Cl2 for 5-10 minutes.  The Fmoc group at the N-terminus was cleaved by the addition 
of a 25/75 solution of piperidine/DMF (30 mL), followed by agitation with nitrogen for 
three minutes.  The resin was filtered, and fresh piperidine/DMF (30 mL) was added.  
After agitating for 20 minutes, the resin was filtered and washed with DMF six times.   
A solution of Fmoc-Asp(OBut)-OH (3.85 g, 9.35 mmol), HBTU (3.48 g, 9.17 
mmol), and HOBt (1.26 g, 9.35 mmol) in 20 mL of anhydrous DMF was prepared.  After 
the solution became homogeneous, DIPEA (3.28 mL, 18.70 mmol) was added, and the 
resulting mixture was added immediately to the resin.  The resin was then agitated for 
one hour, filtered, and washed with DMF (three times).  A 25/75 solution of 
piperidine/DMF (30 mL) was added, and the resin agitated for three minutes.  After 
filtration, piperidine/DMF was again added to the resin followed by agitation for 20 
minutes.  The resin was then washed with DMF (six times).  The above amino acid 
addition procedure was repeated for Fmoc-Gly-OH, Fmoc-Arg(Pbf)-OH, and a second 
unit of Fmoc-Gly-OH. 
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Following the addition of the second Gly unit, a solution of 6-bromohexanoic acid 
(1.82 g, 9.35 mmol) and HOBt (1.26 g, 9.35 mmol) was prepared in 15 mL of dry DMF.  
DIC (1.45 mL, 9.35 mmol) was added drop wise to the solution and stirred for 20 
minutes.  The activated solution was added to the resin and agitated for one hour.  After 
filtration, the resin was washed with DMF (six times) followed by CH2Cl2 (four times) to 
remove any residual DMF.   
Two different approaches were then used to prepare the final azide-functionalized 
SDGRG 5.  Initial efforts cleaved the peptide from the resin after this coupling reaction 
whereas latter studies streamlined the synthesis by introducing the azide-functionality 
prior to resin cleavage.  To generate the material by the first method, the peptide was 
deprotected and cleaved from the resin by agitating with a 95/2.5/2.5 solution of 
TFA/H2O/TIPS (30 mL) for three hours.  The solution was filtered, and the cleavage 
procedure was repeated with 30 mL of fresh solution and 30 minutes of agitation.  The 
resin was then washed with CH2Cl2 (three times), and the filtrate was concentrated by 
rotary evaporation, precipitated into diethyl ether, and stored at 4 ºC for several hours 
before filtration.  The solid was isolated by filtration, rinsed with diethyl ether (three 
times), and dried under vacuum overnight to afford the Br-terminated oligopeptide 4 as a 
white powder in nearly quantitative yield (based upon the given resin-loading density).  
HRMS-FAB (m/z): [M+H]+ calculated for C23H39N8O10Br 667.205, found 667.207. 
 1H 
NMR (d6-DMSO, 400 MHz):  ? (DMSO = 2.50 ppm) 11.90 (br, 2H), 8.30 (br, 1H), 8.20 
(d, J = 7.9 Hz, 1H), 8.07 (m, 2H), 7.88 (d, J = 7.7 Hz, 1H), 7.72 (br, 1H), 7.16 (br, 2H), 
4.64 (m, 1H), 4.22 (m, 2H), 3.66 (m, 8 H), 3.50 (tr, J = 6.7 Hz, 2H), 3.07 (m, 2H), 2.13 
(tr, J = 7.2 Hz, 2H), 1.78 (m, 2H), 1.64 (br, 2H), 1.50 (m, 6H), 1.35 (m, 2H) ppm.  13C 
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NMR (d6-DMSO, 100 MHz):  ? (DMSO = 39.52 ppm) 172.7, 172.0, 171.9, 170.7, 169.4, 
168.7, 156.8, 61.4, 55.0, 52.3, 49.4, 42.1, 40.4, 36.4, 35.1, 35.0, 32.1, 29.1, 27.3, 24.9, 
24.4 ppm.  ATR-FTIR:  O-H and N-H 3286.1, C-H 2937.0, C=O 1644.1, N-H 1531.9  
cm-1.   
Bromide-terminated SDGRG 4 (1.17 g, 1.75 mmol) was dissolved in DMSO (3.5 
mL, 0.5 M), and NaN3 (0.13 g, 2.00 mmol) was added to the solution.  The reaction was 
allowed to proceed for 12-18 hours at room temperature after which the solution was 
filtered through Celite.  Following rotary evaporation and Kugelrohr distillation to 
remove the DMSO, the crude product was dissolved in a minimal amount of methanol, 
and the residual salts were removed by filtration.  The remaining solution was 
precipitated from diethyl ether and filtered to afford the azide-terminated sequence 5 as a 
white powder (1.09 g, 99% yield).  HRMS-FAB (m/z): [M+H]+ calculated for 
C23H39N11O10 630.296, found 630.296.  
1H NMR (d6-DMSO, 400 MHz): ? (DMSO = 
2.50 ppm) 8.36 (br, 1H), 8.27 (m, 2H), 8.07 (m, 2H), 7.72 (d, J = 7.4 Hz, 1H), 7.23 (br, 
2H), 4.58 (m, 1H), 4.23 (m, 1H), 4.14 (m, 1H), 3.59 (m, 8H), 3.29 (tr, J = 6.8 Hz, 2H), 
3.07 (m, 2H), 2.13 (tr, J = 7.3 Hz, 2H), 1.76 (m, 2H), 1.50 (m, 6H), 1.28 (m, 2H) ppm.  
13C NMR (d6-DMSO, 100 MHz):  ? (DMSO = 39.52 ppm) 173.4, 172.7, 172.6, 172.4, 
170.6, 169.3, 168.8, 157.2, 61.8, 55.3, 52.4, 50.6, 49.7, 42.5, 42.0, 40.5, 36.8, 35.0, 29.4, 
28.1, 25.8, 24.7, 24.5 ppm.  ATR-FTIR: O-H and N-H 3261, N=N=N 2097, C=O 1645 
cm-1.  
 
 
  36 
2.4.6 Synthesis of Azide-terminated SDGRG (5) using Method 2   
 
The second method for preparing the azide-functionalized SDGRG 5 followed the 
same methodology as the first approach until the resin cleavage.  Following the addition 
of 6-bromohexamoic acid and prior to resin cleavage as previously described, a solution 
of NaN3 (0.61 g, 9.35 mmol) in 85/15 DMF/MeOH was added to the resin and agitated 
for three hours.  The solution was filtered, and a fresh NaN3 solution was added to the 
resin and agitated for another three hours.  After filtering the solution from the resin, the 
resin was washed with 85/15 DMF/MeOH several times to remove residual NaN3 and 
then DCM to wash away the residual DMF.  The oligopeptide was then cleaved by 
agitating the resin with 95/2.5/2.5 TFA/H2O/TIPS (30 mL) for three hours.  The filtrated 
was collected in a clean flask, and the resin was washed with fresh cleavage solution and 
DCM several times.  The solution was concentrated on a rotary evaporator and dissolved 
in minimal MeOH.  The oligopeptide was precipitated from diethyl ether and isolated by 
filtration.  The resulting white solid was isolated in 99% yield.  Characterization of the 
resulting materials agreed with the data previously collected by 1H and 13C NMR, 
HRMS, and ATR-FTIR.  
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2.4.7 Click Reaction Conditions for Polyester-graft-SDGRG (6)   
 
Azide-terminated SDGRG 5 (23 mg, 0.036 mmol) was dissolved in 2 mL of water 
and heated to 80 ˚C.  The acetylene-functionalized homopolymer 3 (100 mg, 0.72 mmol 
acetylene) was dissolved in 1 mL of acetone and added drop wise to the rapidly stirring 
solution.  Sodium ascorbate (122 mg, 0.61 mmol) and copper (II) sulfate pentahydrate 
(79 mg, 0.32 mmol) were then added, and the resulting dispersion was heated to 100 ºC 
for three hours and then lowered to 80 ºC and allowed to proceed overnight.  The reaction 
mixture was cooled to room temperature, diluted with a saturated NaCl aqueous solution, 
and extracted five times with CH2Cl2.  The combined organic layers were then dried over 
MgSO4 and concentrated by rotary evaporation.  The resulting product 6 was dried 
overnight under vacuum to yield a yellow viscous liquid in 50-70% yield.  GPC (DMF, 
after 1 month):  Mn = 19,400 g/mol, PDI = 1.07.  
1H NMR (CDCl3, 600 MHz):  ? (CHCl3 
= 7.26 ppm) 6.70-7.80 (m, 6 H), 4.73-4.75 (m, 1 H), 4.30-4.32 (m, 2 H), 4.07-4.17 (m, 4 
H), 3.64 (tr, J = 6.4 Hz, 2 H), 2.73 (m, 2 H), 2.38-2.60 (m, 6 H), 2.02 (tr, J = 2.5 Hz, 1 
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H), 1.64-1.78 (m, 8 H), 1.58 (m, 6 H) ppm.  ATR-FTIR: C-H 2944, C-H 2864, C=O 1722 
cm-1. 
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CHAPTER 3 
OLIGOPEPTIDE-FUNCTIONALIZED POLYOLEFINS:  SYNTHESIS AND 
CHARACTERIZATION OF A MODULAR CLASS OF POLYELECTROLYTES 
 
3.1 Oligopeptide-functionalized Polyolefins as a Modular Class of Polyelectrolyte 
Materials 
Polyelectrolytes display unique properties as a result of their macromolecular 
nature and electrochemical properties.  The resulting properties of these materials along 
with their widespread applicability in areas such as gene therapy,1-3 tissue engineering,4,5 
coatings,6 membranes,7,8 and oil recovery9,10 have drawn physicists, chemists, and 
biologists alike to study these materials.  Polyelectrolytes display long-range interactions 
as a function of their charge density and charge strength, and other parameters such as 
backbone flexibility and molecular architecture (hydrogen bonding capability, 
hydrophobic forces) also play key roles in the resulting material properties.11   
Despite extensive synthetic and characterization efforts, questions remain 
concerning the correlation between polymer architecture and the resulting properties.  
The lack of this fundamental knowledge is a result of the difficulties in preparing 
polyelectrolytes with well-defined architectures and parameters, which can be tuned to 
explore a range of polyelectrolyte properties.  In response to this need, numerous research 
groups have pursued different avenues to achieve well-defined architectures and create 
systems with a large degree of modularity.  
Conventional polyelectrolytes are typically vinyl polymers (i.e., based on 
CH2=CH-X monomers) prepared by anionic
12 and free-radical11,13 methods, where the 
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charge character is directly on the polymer backbone or on a pendent group.  The 
negatively or positively-charged X-group is typically in the form of carboxylate,14 
ammonium,13,15 sulfonate,16 or pyridinium moieties.17   The close proximity of pendent 
charged groups gives rise to steric and charge repulsion that present both synthetic and 
characterization challenges.  As such, new syntheses that can simultaneously provide 
spacing of pendent, charged moieties and thus variable charge density would be 
valuable.11  Another challenge with such systems is that they result in different molecular 
shapes based upon the ionic strength of the surrounding environment.  Therefore, by 
eliminating the shape dependence on ionic strength, rigid polymers can provide 
information that is difficult to interpret from vinyl-based systems.  One example of the 
tunability of rigid-rod polyelectrolytes is provided by Wegner and coworkers where they 
synthesized sulfonated phenylenes and varied parameters such as charge density to 
determine their effect on the resulting material properties.18 
Building on the unique properties of polyelectrolytes, branched polyelectrolyte 
systems offer the ability to generate a range of structures, from linear polymers to soft 
nanoparticles that can be synthesized by controlling the degree of branching.  In general, 
branched polyelectrolytes with well-defined molecular weights, branching degrees, and 
branching type are difficult to synthesize due to lack of functionality tolerance in many 
controlled polymerization techniques, making it challenging to elucidate the structure-
property relationships in the resulting materials.  Methods such as anionic12, free-
radical11,13, macromonomer11, and Suzuki coupling11 based techniques have been 
employed to synthesize such architectures and have utilized protection/deprotection 
strategies to incorporate various ionic groups.  Due to its functional group tolerance,19,20 
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metathesis chemistry and ROMP in particular enable the synthesis of wide variety of 
olefin-based polyelectrolytes with pendent carboxylate,14,21 ammonium,22 and 
oligopeptide23-25 groups.  With the introduction of advanced ruthenium catalysts, ROMP 
enables the incorporation of carboxylic acids, alcohols, azides, and amides without the 
need for protecting groups and only requiring protection strategies for primary amines 
and unsaturation.   
Herein, unique oligopeptide-functionalized polyelectrolytes based on a polyolefin 
backbone are introduced and offer control over parameters such as backbone rigidity, 
sign of the charged group, functional group incorporation, and molecular weight.  These 
polyelectrolytes were synthesized on a multi-gram scale using Fmoc-based SPPS26 for 
monomer preparation followed by ROMP (Figure 3-1).  In these studies, structure-
property relationships were established by varying charge density (i.e., graft length and 
charge spacing) along the polymer backbone and characterizing solution properties by 
static and dynamic light scattering.  The materials described here contain oligolysine and 
poly(ethylene glycol) (PEG) grafts, offering potential for applications in nucleic acid 
encapsulation and delivery.  
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Figure 3-1. General monomer and polymer synthesis 
 
3.2 Results and Discussion 
3.2.1 Synthesis and Characterization of Lysine-containing Monomers  
 Cyclooctene monomers 7 and 8, containing pentalysine and lysine pendent 
groups, respectively, were prepared by Fmoc-based SPPS on a 2-chlorotrityl chloride 
resin with loading densities ranging from 1.0-1.4 mol/g.26  Before cleavage from the 
resin, the N-terminus of the peptide sequence was capped with 5-carboxylic acid-1-
cyclooctene.27-29  The oligopeptide-substituted monomers were cleaved from the solid 
phase resin under mildly acidic conditions (4:1 dichloromethane:trifluoroethanol 
(DCM:TFE)), which enabled removal of the macromonomer from the resin without 
cleaving the protecting groups.  Monomers 7-9 were characterized by 1H and 13C NMR 
spectroscopy, FTIR spectrometry, elemental analysis, mass spectrometry, and/or GPC.  
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In the 1H NMR spectra of 7-9, the cyclic olefin protons were seen at ~5.6 ppm.  In 
addition, GPC traces of macromonomers 7 and 9 showed them to be monomodal and of 
very low polydispersity.  Due to the affinity of amines for ruthenium, the Boc-protected 
forms of 7 and 8 were used for ROMP. 
3.2.2 Synthesis and Characterization of Polycyclooctene-graft-lysine 10  
Cyclooctene-functionalized monomers 7-9 were polymerized by ROMP using 
Grubbs Generation III catalyst ([(H2IMes)(3-Br-pyr)2(Cl)2Ru=CHPh])
30 to give the 
polymers shown in Figures 3-1 and 3-2 and characterized in Table 3-I.  Initial studies 
focused on the homopolymerization of 5-pentalysine(Boc)-1-cyclooctene 7.  Exploration 
of a variety of solvents and temperatures led to optimal polymerization conditions of 0.5 
M of 1 in 10/90 DCM/TFE at room temperature for 40 minutes.  Under these conditions, 
the Boc-protected polymer was obtained in greater than 80% conversion in 40 minutes 
and was then purified by precipitation from ether in 80-86% yield.  The polymer was 
characterized by 1H and 13C NMR.  The ring-opening of the cyclic olefin monomer was 
confirmed by the 1H NMR spectrum, which showed an upfield shift from 5.6 to 5.2 ppm 
in the olefin proton signals.  GPC of this Boc-protected polymer was not feasible in THF 
or chloroform due to its limited solubility, and a low dn/dc with respect to DMF 
prevented reliable GPC characterization in this more polar eluent. 
Polycyclooctene-graft-pentalysine(Boc) was deprotected with 4 M HCl in 1,4-
dioxane and methanol to give 10 (Figure 3-2) as a white powder in 95% yield after 
precipitation into acetone.  Trace macromonomer was removed by centrifugation using a 
filter device (Millipore Amicon Ultra) with a molecular weight cutoff (MWCO) of 
10,000 g/mol.  10 was then freeze-dried and characterized by 1H and 13C NMR, GPC,  
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Figure 3-2. Oligopeptide-functionalized polyelectrolytes 
 
and static and dynamic light scattering.  GPC was performed in 0.5 M aqueous acetic 
acid with 0.3 M Na2SO4 using ultraviolet (UV) and refractive index (RI) detection.  The 
GPC trace of 10 is shown in Figure 3-3, indicating the presence of polymer with 
monomodal molecular weight distribution and only trace amounts of macromonomer or 
cyclic oligomers.  10, prepared using a 50:1 ratio of Grubbs Generation III catalyst, had a 
GPC-estimated number-average molecular weight (Mn) of 87,000 g/mol and a 
polydispersity index (PDI) of 1.7 against PEG standards.  Given the molecular weight 
overestimation expected from GPC on these graft copolymers, the molecular weight 
given by GPC is in reasonable agreement with theoretical values (for DP = 50, Mn of the 
chloride salt is approximately 49,000 g/mol).  However, the solution properties of these 
densely-grafted polyelectrolytes in water make light scattering an important 
characterization technique as discussed in later sections.  
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Figure 3-3. Aqueous GPC chromatograms of deprotected 7 (dashed) and 10 (solid) 
in 0.5 M acetic acid, 0.3 M sodium sulfate aqueous buffer at a flow rate of 0.5 
mL/min 
 
Compound 2 was sufficiently soluble to carry out the polymerization at a higher 
concentration than 1 of 1.2 M in 50/50 DCM/methanol at room temperature.  Boc-
protected 11 was prepared using a 50:1 monomer:catalyst ratio with Grubbs Generation 
III catalyst, and the resulting polymer was amenable to characterization by GPC in THF.  
GPC relative to PEG standards on Boc-protected 11 gave Mn and Mw values of 7,500 and 
11,000, respectively, with a PDI of 1.5.  Using poly(methyl methacrylate) (PMMA) 
standards, these values were estimated at 13,000 (Mn) and 18,000 (Mw) with a PDI of 1.4.  
At a target DP of 50, the anticipated Mn of 11 was approximately 16,000 g/mol. 
Monomer 7 was copolymerized with PEG-functionalized macromonomer 9 (Mn = 
1,200 g/mol, Mw = 1,360 g/mol, PDI = 1.09 relative to PEG standards according to THF 
GPC), which was prepared by anionic polymerization of ethylene oxide from 5-
hydroxycyclooctene by Kurt Breitenkamp (Emrick Research Group, Ph.D. 2009).  This 
ROMP copolymerization to synthesize 12 was catalyzed by Grubbs Generation III 
catalyst and proceeded to high conversion in seconds to minutes at ambient temperature.  
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In order to completely solubilize both monomers 7 and 9, the reaction was run at 0.6 M in 
50/50 DCM/MeOH.  Similar PEG-containing macromonomers are typically polymerized 
at higher concentrations to reduce cyclization, but due to the high percentage of solids in 
this polymerization, high reaction concentrations were not feasible.  A 1:1 feed ratio of 
monomers 7 and 9 led to random copolymers composed of approximately 70:30 
pentalysine:PEG grafts based on 1H NMR spectroscopy.  Before deprotection of the acid-
labile Boc group, these pentalysine and PEG-containing graft copolymers were also 
characterized by GPC in THF to reveal molecular weights in the range of the targeted DP 
of 50, which puts the theoretical Mn around 60,000-65,000 g/mol depending upon the 
copolymer composition (PEG standards:  Mn = 36,000, Mw = 61,000, PDI = 1.7 and 
PMMA standards: Mn = 51,000, Mw = 75,000, PDI = 1.5). At a DP of 50, with a 70:30 
pentalysine:PEG ratio of the monomer units, the expected Mn is about 63,000 g/mol.  
Boc-protected 12 was deprotected according to the same procedure as 10 and 11 (4 M 
HCl in dioxane, methanol, three hours, room temperature).  12 was precipitated into 
diethyl ether, isolated in 93% yield as an off-white solid, and characterized by NMR 
spectroscopy and GPC.  Dynamic and static light scattering were then used to analyze 12 
in solution. 
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Table 3-I. Structure and characterization of 10, 11, and 12.  All polymerizations 
were catalyzed by Grubbs Generation III catalyst using a 50:1 monomer:catalyst 
ratio. 
 
 
 
3.2.3 Light Scattering Studies of 10, 11, and 12  
Static and dynamic light scattering were used to determine the solution properties 
of 10-12 (Figure 3-2) as summarized in Table 3-II.  Initial studies focused on the effect 
of salt concentration and pH on the solution behavior of 10 (Figure 3-4, Table 3-II).  
Subsequent experiments focused on the effect of varying the graft length (1 versus 5 
lysine groups) by comparing 11 with 10 (Figure 3-5, Table 3-II) and the effect of 
increasing charge spacing while maintaining the polymer hydrophilicity using 12 (Figure 
3-5, Table 3-II). 
3.2.3.1 Light Scattering Studies of 10: The Effect of Ionic Strength   
Initial studies focused on the solution behavior of 10 with an emphasis on the 
effect of ionic strength and pH.  The weight-average molecular weight (Mw), radius of 
gyration (Rg), and second viral coefficient (A2) were determined by static light scattering 
(SLS) from the generation of Zimm plots for various conditions (Figure 3-4).  While the 
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pKa of lysine’s side chain amine varies based on its environment (as seen in proteins), it 
has a pKa value of around 10 in its free amino acid form.
31  As solutions in neutral water, 
the oligolysine grafts become protonated.  If all the lysine groups release their chloride 
counterions when dissolved in water, the observed Mw of 48,000 correlates to a DP of 
around 60, in good agreement with the targeted DP of 50.  Even after considering that 
some counterions will remain associated with the polymer due to counterion 
condensation,32,33 dispersion of individual polyelectrolyte molecules is seen in the 
concentration range studied.  No aggregation of these highly charged, amphiphilic 
polymers was seen.  The positive second viral coefficient (A2) further indicated this 
polyelectrolyte to be in the good solvent regime.  An Rg of 25 nm for 10 was measured in 
0.1 M NaCl aqueous solution.  This measured Rg is considerably larger than the Rg of a 
Gaussian chain, calculated to be 6 nm based on a monomer contour length of 1.2 nm and 
a degree of polymerization of 60 (based on polymer radius of gyration: Gaussian, 
Rg=(1/6)
1/2(Llp)
1/2; Rod-like, Rg=(1/12)
1/2L where L: chain contour length. lp: persistence 
length (=1.2nm)).  At a fully-extended conformation, the estimated Rg would equal 23 
nm.  This experimentally-determined Rg of 10 indicates a significantly expanded 
conformation in low salt solution. 
To investigate the effect of solution ionic strength on polymer conformation, z-
average Mw, A2, and Rg of 10 were measured in 0.5 M NaCl solutions. The decreased A2 
value of 10 observed in this environment indicated that the solvent quality became poorer 
at elevated ionic strength, and based on the Zimm plot, an Mw value comparable to what 
was found in low salt solution was observed at this high salt concentration.  The slight 
discrepancy seen in the values of Mw at 0.1 M and 0.5 M NaCl can be attributed to the 
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standard practice of ignoring salt effects in Zimm plot analysis.  The Rg of 10 was 
significantly reduced from 25 nm in a 0.1 M NaCl solution to 15 nm in a 0.5 M NaCl 
solution. 
 
Figure 3-4. Zimm plot of SLS data (left) and DLS (right) of 10 in 0.1 M aqueous 
NaCl at 25
o
C.  Based on DLS, the inverse of relaxation time, 1/? , as a function of the 
scattering vector squared, q
2
, is plotted at several concentrations to determine the 
hydrodynamic radius Rh of 10. 
 
Figure 3-4 shows the hydrodynamic radius (Rh) measured by dynamic light 
scattering for 10 in different polymer concentrations. The linear dependence of inverse 
relaxation time on q2 is characteristic of a diffusive motion for 10 in water.  It should be 
noted that in all of the 10 solutions studied, only one relaxation mode was observed.  As 
shown in Table 3-II, Rh changed very little (from 11 nm to 10 nm) in a 0.1 M versus 0.5 
M NaCl aqueous salt solution, which contrasted the strong salt-dependence of Rg.  This 
suggested that even though the size of 10 decreased significantly with increasing ionic 
strength, its hydrodynamic properties were relatively stable despite the solution changes.  
As a measure of chain extension, the Rg/Rh ratio was also calculated at different salt 
concentrations.  The large Rg/Rh value (~2.3) in 0.1 M NaCl aqueous solution suggests a 
highly extended chain conformation, which collapses at higher salt concentration of 0.5 
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Table 3-II. Summary of static and dynamic light scattering studies of 10, 11, and 12 
 
M, as indicated by the lower Rg/Rh (~1.5).  Large Rg/Rh ratios have also been observed 
for polymers with densely grafted neutral side chains, attributed to the molecules 
assuming extended conformations in solution.34-36  The extension of the chain backbone 
in a so-called molecular bottlebrush34 originates from a strong excluded volume 
interaction caused by crowding side chains, which pushes the otherwise flexible polymer 
backbone into an elongated conformation.  Analogous to these bottlebrush molecules, 10, 
which contain pendent protonated lysines, exhibited an extended conformation due to the 
combined effects of steric and electrostatic repulsion of the oligopeptide side chains.  
This electrostatic repulsion was significantly screened when the solution ionic strength 
was increased from 0.1 to 0.5 M NaCl, as illustrated in the reduced Rg/Rh value in the 0.5 
M NaCl solutions.  It should also be noted that in high salt solutions, steric crowding 
alone from relatively short pendent lysine chains is not sufficient to support an extended 
polymer conformation.  An extensive computational modeling study is currently being 
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undertaken to quantify the relative contributions of steric crowding and electrostatic 
interaction on conformational properties of polymers grafted with charged side chains. 
3.2.3.2 Light Scattering Studies of 10:  pH Effects 
10 was seen to assume an extended conformation under conditions at which the 
grafts are largely protonated, due to a combination of steric crowding and electrostatic 
repulsion of the positively-charged grafts in 0.1 M NaCl solution.  Rg and Rh of 10 were 
also measured at pH 2 and pH 12 (Table 3-II) (no added NaCl).  At pH 2, 10 was 
observed to be slightly more extended than at pH 7, a result of lower salt screening 
effects.  In the high pH environment, the number of protonated amines decreases, and the 
grafts become more flexible, resulting in a reduction of Rg and Rh.  Unscreened 
electrostatic repulsion among residual charges in the grafts is likely responsible for the 
conformation that is characterized by a high Rg/Rh ratio at 0.1 M NaCl.   
3.2.3.3 Light Scattering Studies of 11 
To further explore the effect of the pendent oligolysine grafts on solution 
properties, 11 was studied by static and dynamic light scattering in 0.1 M and 0.5 M 
NaCl aqueous solutions at neutral pH (Figure 3-5).   The Rh of 11 was found to be 
extremely small (on the order of 6.5 and 4.4 nm for 0.1 M and 0.5 M NaCl solutions, 
respectively).  The Rg of 11 in 0.1 M NaCl solution was found to be larger than would be 
expected for a globular polymer conformation.  The molecular weight indicated 
individual polymer chains dispersed in water.  Based on Rg/Rh, 11 is viewed as exhibiting 
highly anisotropic conformation, which was even greater than the anisotropic behavior 
seen in 10.  11 was in a poor solvent regime at high salt concentrations as indicated by 
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the negative A2 value measured in 0.5 M NaCl solution.  Evaluation of these various 
parameters suggests that 11 behaves as a typical hydrophobic polyelectrolyte.  Numerous 
studies37-41 have determined that when dissolved in water, strongly-charged hydrophobic 
polyelectrolytes adopt a “pearl-necklace” conformation in which the polymer chain 
consists of multiple mini-aggregates comprised of several monomer units, or “pearls,” 
connected by a string of uncollapsed monomers.  Due to the repulsion between pearls, the 
pearl-necklace conformation becomes stiff.  When the solution ionic strength was 
increased from 0.1 M to 0.5 M, the electrostatic repulsion among the pearls was screened, 
and the entire chain collapsed into a globular structure as evidenced by the decrease in Rg 
and Rh.  The values of Rg and Rh changed from 27 nm and 6.5 nm at 0.1 M to 9.0 nm and 
4.4 nm at 0.5 M NaCl.  Although these light scattering results for 11 are consistent with 
the pearl-necklace model, more direct observation of “pearls” is desirable.  While a direct 
observation of pearls formed by a single homopolymer molecule continues to be a 
challenge, 11 appears to be an excellent candidate for future experimental verification of 
theoretical predictions.   
 
Figure 3-5. Zimm plot of SLS data for 11 (left) and 12 (right) in 0.1 M aqueous NaCl 
at 25 
o
C 
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3.2.3.4 Light Scattering Studies of 12 
Aqueous solutions of 12 were also studied by light scattering at both low and high 
ionic strengths to explore the effect of charge spacing by the introduction of non-ionic, 
hydrophilic moieties (Figure 3-5).  Compared to 10, the Rg and Rh of the PEGylated 
copolymer were substantially higher.  Given that the molecular mass of the PEG grafts 
are comparable to pentalysine and that the targeted DP of 12 is the same as 10, the 
expansion of 12 was unexpected.  Incorporating non-ionic, hydrophilic PEG grafts was 
expected to reduce the strong electrostatic repulsion among the pentalysine moieties, 
which was shown to be responsible for the highly anisotropic conformation of 10.  
Therefore, based on the dilution of the electrostatic repulsion, 12 was expected to be 
smaller.  However, the effective molecular weight of 12 based on light scattering was 
measured to be about three times larger than the value obtained by GPC.  Furthermore, 
the copolymer conformation was stable to drastic changes in ionic strength, in contrast to 
the behavior of 10.  From these observations, the copolymer chains likely formed 
aggregated structures composed of (on average) three chains.  One possible origin of such 
aggregation could be the hydrophobic nature of the polyolefin backbone.  The molecular 
origin of why such aggregates are comprised of only a finite number of these copolymer 
molecules remains to be fully investigated.  The question of the dependence of the 
unimer-to-multimer transition on the PEG content is a fundamental problem in 
understanding the molecular origin of multimer formation. 
3.3 Conclusions 
Utilizing a combination of solid phase peptide synthesis and ring-opening 
metathesis polymerization, new polyelectrolyte materials were prepared, containing 
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hydrophobic backbones with pendent lysine and PEG grafts.  These materials were easily 
prepared in multi-gram quantities, making them attractive candidates for material-based 
applications. 
The solution behavior of these polyelectrolytes was tailored by changing the 
peptide graft length as well as the spacing of the charged moieties.  Despite the flexible 
polycyclooctene backbone, polycyclooctene-graft-pentalysine 10 exhibited an extended 
conformation in low ionic strength aqueous solutions due to combined influences of 
steric crowding and electrostatic repulsion.  Screening of electrostatic repulsion at high 
ionic strength resulted in a more condensed structure.  Pearl-like structures were found 
for the monolysine derivative 11 where the hydrophobic backbone collapsed on itself in 
the aqueous environment.  However, with the introduction of only 30 mole percent PEG 
grafts, the resulting random copolymer 12 no longer adopted an extended conformation 
based on the Rg and Rh values in solution.  Instead, small aggregates with a finite number 
of polymer molecules are formed.  Various other structural parameters such as negative 
versus positive charge and PEG length are currently being studied to better understand 
the structure-property relationship of these polyelectrolytes and to explore their potential 
in nucleic acid delivery (for the cationic polyelectrolytes) and cartilage mimetics (in the 
case of negatively-charged derivatives). 
3.4 Experimental Details 
3.4.1 Materials  
Piperidine (reagent plus, 99%), 2,2,2-trifluoroethanol (TFE) (99.5%), 
diisopropylethylamine (biotech grade, 99.5%), methanol (anhydrous, 99.8%), 3-
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bromopyridine (99%), and Grubbs Generation II catalyst ((1,3-Bis-(2,4,6-
trimethylphenyl)-2-imidazolidinylidene) 
dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium, C46H65Cl2N2PRu) were 
purchased from Sigma Aldrich (Saint Louis, MO).  N,N-Dimethylformamide (EM 
Science, guaranteed reagent, 99.8% and EM Science, anhydrous, 99.8%) and pentane 
(EM Science, ACS reagent) were bought from VWR International (West Chester, PA).  
Sodium chloride (reagent grade), HCl (concentrated), Millipore Amicon Ultra (MWCO 
10,000) centrifugal filter devices, and Millipore hydrophilic PVDF membrane filters 
(0.22 mm diameter) were obtained from Thermo Fisher Scientific Inc. (Waltham, MA).  
Fmoc-Lys(Boc)-OH, 1-hydroxybenzotriazole (HOBt) hydrate, O-(benzotriazol-1-yl)-
N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU), and 2-chlorotrityl chloride 
resin (1.4 mmol/g, 100-200 mesh) were purchased from Advanced ChemTech 
(Louisville, KY).  Deuterated solvents d6-DMSO and D2O were obtained from 
Cambridge Isotopes (Andover, MA).  CH2Cl2 was washed according to standard 
procedures42 and distilled over CaH2.  TFE was distilled over sodium bicarbonate.
42  All 
other materials were used without additional purification.   
3.4.2 Instrumentation 
NMR spectroscopy was acquired on a Brüker Avance400 (1H) and 100 (13C) MHz 
NMR using a Brüker BBO5 probe.  Mass spectrometry data were obtained on a JEOL 
JMS700 MStation high resolution two-sector mass spectrometer with low resolution 
electrospray ionization (ESI).  Gel permeation chromatography (GPC) was performed in 
tetrahydrofuran (THF) and aqueous eluents.  For analysis in THF, a KNAUER HPLC 
Pump K-501, UV Detector K-2600 (absorbance measured at 232 nm and 260 nm), and RI 
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Detector K-2301 were utilized and equipped with three PLgel 5 mm MIXED-D 300 x 7.5 
mm columns (flow rate = 1.0 mL/min).  Aqueous GPC was performed in 0.5 M acetic 
acid and 0.3 M sodium phosphate buffer with a flow rate of 0.5 mL/min.  The aqueous 
system was comprised of a HP Series 1050 Pump, HP 1047A RI Detector, and Waters 
486 Tunable Absorbance Detector (? = 232 nm) utilizing three Waters Ultrahydrogel 
Linear Columns (mixed beads, 7.8 x 300 mm).  Elemental analysis (CHN testing) was 
performed by Schwarzkopf Microanalytical Laboratory (Woodside, NY).  Light 
scattering studies were performed with an ALV light scattering apparatus equipped with 
an ALV-5000 board. A green laser (COHERENT) with a wavelength of 514.5 nm was 
used as light source, and the temperature of the sample holder was held constant at 
25+0.1 °C by a circulating water bath.  
3.4.3 Synthesis of 5-pentalysine(Boc)-1-cyclooctene (7) 
 
The pentalysine-functionalized macromonomer 7 was synthesized via Fmoc-
based SPPS with the coupling agent HBTU using a 2-chlorotrityl chloride resin.  To load 
the resin with the first amino acid unit, the 2-chlorotrityl chloride resin (5.00 g of resin 
with 1.40 mmol of functional groups per gram of resin, 7.00 mmol, 100-200 mesh) was 
weighed into an oven-dried, glass-fritted reaction tube and swollen with dry DCM (40 
mL) for 5-10 minutes.  The resin was filtered, and a solution of Fmoc-Lys(Boc)-OH 
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(6.56 g, 14.00 mmol), dry DIPEA (6.10 mL, 35.00 mmol), and dry DCM (30-40 mL) was 
added to the reaction tube.  The tube was capped, vented, and agitated with nitrogen.  
After 30 minutes, the resin was filtered and rinsed with dry DMF three times.  The 
remaining reactive groups on the resin were capped with a 80/15/5 dry 
DCM/methanol/DIPEA solution (40 mL, 2 x 10 minutes) and then rinsed with reagent 
grade DMF.  The Fmoc group was then removed with a 25/75 piperidine/DMF cleavage 
solution (2 x 40 mL).  The solution was added to the resin, and the resin was agitated for 
three minutes.  Following filtration, fresh cleavage solution was added and agitated for 20 
minutes.  The resin was filtered and rinsed with DMF six times, DCM three times, 
isopropanol three times, and hexanes six times.  The resin was dried by suction filtration 
for 15 minutes, transferred to a vial, and dried under vacuum for 24-36 hours.  The 
loading density was estimated by the change in mass from the starting resin to the final 
resin.  Loading densities for these syntheses were generally in the range of 0.7-1.4 
mmol/g with lower loading densities targeted for longer oligopeptide sequences.  To 
tailor the degree of functionalization of the resin surface, the number of equivalents of the 
amino acid added to the coupling solution was changed.  When using 2.00 eq of amino 
acid as described above, loading densities generally ranged from 1.20-1.40 mmol per 
gram of resin. 
Following the addition of the first amino acid residue, the dried resin (6.61 g, 9.25 
mmol) was transferred to a dry, glass-fritted reaction tube and swollen with 40 mL of 
DCM for five minutes.  Fmoc-Lys(Boc)-OH (21.68 g, 46.27 mmol), HOBt (7.09 g, 46.27 
mmol), HBTU (17.20 g, 45.34 mmol), and DMF (60 mL, reagent grade) were combined 
in an oven-dried round bottom flask, and DIPEA (reagent grade, 16.12 mL, 92.54 mmol) 
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was added to form a clear, yellow solution.  The activated amino acid solution was then 
added to the resin, and the resin was agitated for one hour, filtered, and washed with 
DMF three times.  As previously described for the resin loading, the Fmoc protecting 
group was cleaved with 25/75 piperidine/DMF, after which the resin was washed with 
DMF six times.  The same procedure was utilized to add lysine units until the desired 
oligopeptide sequence length was obtained.  
Following the addition of the final lysine residue, the Fmoc protecting group was 
cleaved, and the resin was thoroughly washed with DMF.  A solution of 5-carboxylic 
acid-1-cyclooctene (prepared in three steps from 1,5-cyclooctadiene27-29, 7.14 g, 46.27 
mmol), HOBt (7.09 g, 46.27 mmol), HBTU (17.20 g, 45.34 mmol), DIPEA (16.12 mL, 
92.54 mmol), and 60 ml of DMF was then added to the resin and agitated from one hour.  
The resin was filtered and washed with DMF and DCM three times.  The macromonomer 
was then cleaved from the resin under mildly acidic conditions (4:1 DCM:TFE).  After 
45 minutes, the resin was filtered into a clean flask, and fresh solution was added.  The 
resin was agitated for another 45 minutes, filtered, and washed with 4:1 DCM:TFE and 
then DCM three times.  This resulting filtrate was concentrated on a rotary evaporator 
and then precipitated into diethyl ether.  After sitting at 4°C for several hours, the product 
was isolated by filtration and then dried under vacuum.  The white, powdery product was 
obtained in 80-85% yield based upon the estimated loading density and was characterized 
by 1H and 13C NMR, ATR-FTIR, low and high resolution mass spectrometry, and 
elemental analysis.  1H NMR (d6-DMSO, 400 MHz): ? (DMSO = 2.50 ppm) 12.49 (br, 1 
H), 7.64-8.03 (br m, 5 H), 6.72 (br, 4 H), 6.40 (br, 1 H), 5.64 (br, 2 H), 4.04-4.30 (br m, 5 
H), 2.86 (br, 10 H), 2.22-2.38 (br m, 2 H), 1.97-2.20 (br m, 3 H), 1.10-1.81 (m, 81 H) 
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ppm. 13C NMR (d6-DMSO, 100 MHz): ? (DMSO = 39.52 ppm) 177.12, 177.08, 173.42, 
171.99, 171.48, 171.41, 171.25, 155.51 (5 C), 129.97, 129.88, 77.31(5 C), 52.70, 52.60, 
52.39, 52.21, 51.81, 43.60, 40.35, 32.25, 31.98, 31.81, 31.67 (2 C), 31.22, 30.74, 29.89, 
29.57, 29.25 (3 C), 29.14, 28.26 (15 C), 27.49, 27.35, 25.44, 25.37, 24.02, 22.53-22.86 
(overlapping, 5 C) ppm.  ATR-FTIR: 3282, 2931, 1683, 1630, 1521, 1452, 1392, 1365, 
1249, 1169, 864 cm-1.  Low resolution ESI (m/z): [M+Na]+ calculated for 
NaC64H114N10O17 1317.83, found 1317.8.  High resolution FAB (m/z): [M+Na]
+ 
calculated for NaC64H114N10O17 1317.8261, found 1317.8959.  Elemental analysis 
(CHN):  calculated C = 59.33, H = 8.87, N = 10.81, found C = 58.28, H = 8.94, N = 
10.44.  
3.4.4 Synthesis of 5-monolysine(Boc)-1-cyclooctene (8) 
 
2-chlorotrityl chloride resin was loaded with lysine as previously described.  
Following the loading of lysine on the resin, the resin was swollen, and a solution of 5-
carboxylic acid-1-cyclooctene, HBTU, HOBt, DMF, and DIPEA was added.  The resin 
was agitated for one hour, filtered, washed with DMF six times, and washed with DCM 
three times.  8 was cleaved from the resin as previously described for compound 7, and 
the resulting white solid was characterized by 1H and 13C NMR, ATR-FTIR, low and 
high resolution mass spectrometry, and elemental analysis.  1H NMR (d6-DMSO, 400 
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MHz): ? (DMSO = 2.50 ppm) 12.39 (br, 1 H), 7.80-7.95 (br m, 1 H), 6.77 (br m, 1 H), 
6.40 (br s), 5.64 (br m, 2 H), 4.05 (br m, 1 H), 2.86 (br m, 2 H), 2.21-2.38 (br m, 2 H), 
1.93-2.21 (m, 3 H), 1.10-1.87 (br, 21 H) ppm. 13C NMR (d6-DMSO, 100 MHz): ? 
(DMSO = 39.52 ppm) 176.99, 176.91, 174.03, 174.02, 155.63, 130.02, 129.98, 129.95, 
77.37, 51.69, 43.58, 43.49, 40.17, 39.96, 39.75, 39.55, 39.34, 39.13, 38.92, 34.26, 32.24, 
32.08, 30.67, 29.88, 29.61, 29.17, 28.97, 28.32, 27.61, 27.42, 25.52, 25.46, 24.10, 24.04, 
22.97 ppm.  ATR-FTIR: 3314, 2929, 2861, 1689, 1646, 1524, 1451, 1392, 1366, 1249, 
1166, 988, 861, 778, 712 cm-1.  Low resolution ESI (m/z): [M+H]+ calculated for 
C20H35N2O5 383.26, found 383.3; [M+Na]
+ calculated for NaC20H34N2O5 405.24, found 
405.2; [M+K]+ calculated for KC20H34N2O5 421.35, found 421.3.  High resolution FAB 
(m/z): [M+H]+ calculated for C20H35N2O5 383.2546, found 383.2558.  Elemental analysis 
(CHN):  calculated C = 62.80, H = 8.96, N = 7.32, found C = 62.30, H = 9.02, N = 7.21. 
Elemental analysis (CHN):  calculated C = 62.80, H = 8.96, N = 7.32, found C = 62.30, H 
= 9.02, N = 7.21.  
3.4.5 Synthesis of PEG1200-functionalized Macromonomer (9)   
 
In a flame dried air-free flask, 5-hydroxycyclooctene (6.8 mL of a 2.0 M solution 
in THF, 13.6 mmol) was added to dry THF (200 mL) while stirring under N2.  The 
solution was titrated with potassium napthalenide (0.2 M in THF) until a slight green 
end-point was observed (~ 70.0 mL).  The cyclooctene alkoxide solution was stirred for 
an additional 30 minutes at room temperature before being cooled to 0 ºC in an ice/water 
bath.  Ethylene oxide (15.0 mL, 340.6 mmol) was condensed at -78 ºC using a stainless 
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steel gas transfer43 manifold and then slowly warmed to room temperature while 
transferring to the cooled cyclooctene alkoxide solution under static vacuum.  The 
reaction mixture was pressurized with argon, sealed, and stirred at room temperature for 
16 hours.  The solution was concentrated, and the residue was purified by column 
chromatography on silica gel (93/7 ? 90/10 CHCl3/MeOH).  The product recovered 
from the column was dissolved in a minimal amount of chloroform and precipitated into 
a hexane/diethyl ether mixture.  A white powder was isolated by filtration and dried 
under vacuum to yield 12.5 g (83% yield) of PEG-functionalized macromonomer 9.  1H 
NMR (CDCl3, 400 MHz) ? (CHCl3 = 7.26 ppm) 5.62 (m, 2 H), 3.28-3.84 (complex, br m, 
114 H), 2.54 (br s, 1 H), 1.28-2.36 (complex br m, 11 H) ppm.  13C NMR (CDCl3, 100 
MHz) ? (CHCl3 = 77.16 ppm) 130.2, 129.6, 81.1, 72.7, 71.0, 70.7, 70.4, 67.8, 61.8, 34.2, 
33.5, 25.9, 25.8, 22.8 ppm.  ATR-FTIR: 3491, 2882, 1467, 1359, 1341, 1280, 1242, 
1100, 1060, 959, 841, 725 cm-1.  GPC (THF, PEG standards): Mn = 1,200 g/mol, Mw = 
1,360 g/mol, PDI  = 1.09. 
3.4.6 Synthesis of Polycyclooctene-graft-pentalysine(Boc) (10 protected).   
 
Polycyclooctene-graft-pentalysine(Boc) (10 protected) was synthesized by 
ROMP of 7.  Macromonomer 7 (0.88 g, 0.68 mmol) was slowly added to a stirring 
solution of dry TFE (1.22 mL).  The solution was vortexed until complete dissolution.  
  62 
Grubbs Generation III catalyst ([(H2IMes)(3-Br-py)2(Cl)2Ru=CHPh]) was prepared 
according to the literature procedure.30  12.0 mg of the catalyst (0.014 mmol, 50:1 
monomer:catalyst ratio) was dissolved in dry DCM (136 mL) in a separate vial and 
immediately added to the macromonomer solution.  The reaction (final concentration 0.5 
M 10/90 DCM/TFE) was vortexed for 5-10 minutes, stirred under nitrogen for a total of 
40 minutes, and quenched with ethyl vinyl ether (~1 mL).  The reaction solution was 
precipitated into diethyl ether and isolated by filtration.  After drying under vacuum, the 
light yellow polymer was obtained in 85% yield and characterized by 1H and 13C NMR.  
1H NMR (d6-DMSO, 400 MHz):  ? (DMSO = 2.50 ppm) 12.52 (br s, 1 H), 7.60-8.20 (br 
m, 5 H), 6.68 (br s, 4 H), 6.38 (br s, 1 H), 5.29 (br s, 2 H), 3.92-4.40 (br m, 5 H), 2.87 (br 
s, 10 H), 1.09-2.32 (complex br m, 86 H) ppm.  13C NMR (d6-DMSO, 100 MHz):  ? 
(DMSO = 39.52 ppm) 173.60, 171.25, 171.00, 155.53, 77.32 (5 C), 51.90-52.10 
(overlapping, 2 C), 31.90, 30.80, 29.20, 28.27 (15 C), 22.40-22.60 (overlapping, 5 C) 
ppm.  Polycyclooctene backbone carbons were not visible by 13C NMR in d6-DMSO. 
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3.4.7 Synthesis of Polycyclooctene-graft-pentalysine (10) 
 
Boc-protected 10 (0.512 g, 0.526 mmol) was dissolved in 5 mL of dry methanol, 
and excess 4 M HCl in 1,4-dioxane (2 mL) was added.  The vented reaction was allowed 
to stir at ambient temperature for several hours.  The reaction solution was concentrated 
and precipitated from acetone.  The product was isolated by filtration, rinsed with 
acetone, and dried under vacuum overnight, yielding 93% (0.479 g, 0.369 mmol) of the 
desired product.  Residual macromonomer was removed by centrifugation with filter 
devices.  The purified polymer was freeze-dried, yielding a white porous solid, and 
analyzed by 1H and 13C NMR and aqueous GPC.  1H NMR (D2O, 400 MHz):  ? (H2O = 
4.79 ppm) 5.28-5.62 (br m, 2 H), 4.18-4.42 (m, 5 H), 2.88-3.10 (m, 10 H), 2.36 (br, 1 H), 
1.23-1.94 (complex br m, 40 H) ppm.  13C NMR (D2O + 2 drops d6-DMSO, 100 MHz):  
? (DMSO = 39.52 ppm)  180.88, 175.58, 175.35 (2 C), 175.12, 132.48 (2 C), 55.10, 
55.02, 54.85, 54.49, 54.35, 40.76, 33.66, 32.14 (5 C), 31.30 (5 C), 27.89 (4 C), 27.79, 
23.84, 23.66 (3 C), 23.57 ppm.  Some polycyclooctene backbone carbons were not 
visible by 13C NMR in D2O/d6-DMSO.  GPC (0.5 M acetic acid, 0.3 M Na2SO4 aqueous 
buffer):  Mn = 87,000 g/mol, Mw = 144,000 g/mol, PDI = 1.7.   
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3.4.8 Synthesis of Polycyclooctene-graft-monolysine(Boc) (11 protected)   
 
Similar procedures were utilized to generate the monolysine derivative as used for 
the pentalysine analog.  The polymerization was performed in 1.2 M 50/50 DCM/MeOH 
at room temperature for three hours and was catalyzed by Grubbs Generation III catalyst 
(50:1 monomer:catalyst).   The resulting polymer was precipitated from diethyl ether, 
isolated in 89% yield, and characterized by 1H and 13C NMR and THF GPC.  1H NMR 
(d6-DMSO, 400 MHz):  ? (DMSO = 2.50 ppm) 12.39 (br s, 1 H), 8.72 (br s, 1 H), 7.29 
(br m, 1 H), 6.37 (br s), 5.32 (br s, 2 H), 4.15 (br s, 1 H), 2.88 (br s, 2 H), 2.21 (br s, 1 H), 
0.9-1.89 (complex br m, 25 H) ppm.  13C NMR (d6-DMSO, 100 MHz):  ? (DMSO = 
39.52 ppm) 174.89, 173.87, 155.56, 129.91. 129.63, 77.33, 51.53, 45.06, 32.99, 32.68, 
32.33, 32.15, 30.53, 30.06, 28.99, 28.46, 28.27, 26.81, 24.78, 22.85 ppm.  GPC (THF, 
PEG Standards):  Mn = 7,500 g/mol, Mw = 11,000, PDI = 1.5.  GPC (THF, PMMA 
Standards):  Mn = 13,000 g/mol, Mw = 18,000, PDI = 1.4.  
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3.4.9 Synthesis of Polycyclooctene-graft-monolysine (11).   
 
11 was deprotected according to the same procedure used for 10 and isolated as 
an off-white solid in 83% yield.  1H NMR (D2O, 400 MHz):  ? (H2O = 4.79 ppm) 5.44 
(br s, 2 H), 4.39 (br s, 1 H), 3.75 (br m, 3 H), 3.00 (br m, 2 H), 2.40 (br s, 1 H), 1.20-2.15 
(complex br m, 16 H) ppm.  13C NMR (D2O + 2 drops d6-DMSO, 100 MHz):  ? (DMSO 
= 39.52 ppm) 175.72, 131.82, 54.35, 54.02, 47.28, 40.74, 33.63, 31.45, 27.88, 23.99 ppm. 
Some polycyclooctene backbone carbons were not visible by 13C NMR in D2O/d6-
DMSO. 
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3.4.10 Synthesis of Polycyclooctene-graft-pentalysine(Boc)-co-polycyclooctene-graft-
PEG (12 protected) 
 
In a representative polymerization, 7 (0.52 g, 0.40 mmol) and 9 (0.49 g, 0.40 
mmol) were copolymerized at room temperature with Grubbs Generation III catalyst 
(50:1 monomer:catalyst) in 0.6 M 50/50 DCM/MeOH.  The reaction proceeded for three 
hours under nitrogen and was quenched with ethyl vinyl ether.  The polymer was 
precipitated from diethyl ether, isolated by filtration, and freeze-dried.  The Boc-
protected polymer was isolated in 71% yield as an off-white solid.  The resulting material 
was analyzed by 1H and 13C NMR and was determined to be composed of 70/30 mole 
percent pentalysine(Boc)/PEG1200.  The relative molecular weight was estimated by 
GPC.  1H NMR (d6-DMSO, 400 MHz):  ? (DMSO = 2.50 ppm) 12.49 (br s, 1 H), 7.65–
8.14 (br m, 5 H), 6.69 (br s, 5 H), 6.38 (br s), 5.33 (br m, 4 H), 4.55 (br s, 2 H), 4.05-4.38 
(br m, 5 H), 3.10-3.79 (complex br m, 114 H), 2.85 (br m, 10 H), 0.98-2.32 (complex br 
m, 98 H) ppm.  13C NMR (d6-DMSO, 100 MHz):  ? (DMSO = 39.52 ppm) 173.42, 
171.50, 171.20, 155.51, 129.94, 77.30 (5 C), 72.35, 70.15, 69.80, 67.51, 60.22, 52.22, 
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51.76, 31.83, 30.73, 29.14, 28.26 (15 C), 22.66 (5 C), 22.50 ppm.  Some polycyclooctene 
backbone carbons were not visible by 13C NMR in d6-DMSO.  GPC (THF, PEG 
Standards):  Mn = 36,000 g/mol, Mw = 61,000, PDI = 1.7. 
3.4.11 Synthesis of Polycyclooctene-graft-pentalysine-co-polycyclooctene-graft-PEG 
(12).   
 
The Boc-protected copolymer (12 protected) was deprotected and purified using 
the same conditions as 10.  The final product was an off-white solid and obtained in 93% 
yield.  1H NMR (D2O, 400 MHz):  ? (H2O = 4.79 ppm) 5.44 (br s, 4 H), 4.38 (br s, 5 H), 
3.08-3.20 (m, 2 H), 2.85-3.08 (m, 10 H), 1.18-2.52 (complex br m, 53 H) ppm.  13C NMR 
(D2O + 2 drops d6-DMSO, 100 MHz):  ? (DMSO = 39.52 ppm) 175.67, 175.37 (2 C), 
175.15, 73.32, 71.77, 71.15, 61.97, 55.16, 54.51, 40.80, 32.25, 31.37, 27.97, 27.87, 23.72, 
23.61 ppm.  GPC (0.5 M acetic acid + 0.3 M Na2SO4 aqueous buffer):  Mn = 45,000 
g/mol, Mw = 91,000, PDI = 2.0.  
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3.4.12 Light Scattering Studies:  Solution Preparation   
NaCl solutions with concentration of 0.1 M and 0.5 M were prepared by 
dissolving corresponding amounts of NaCl pellets in water purified by a MilliQ UF 
system (Millipore, Billerica, MA) with a resistance of 18.2 ?.  To adjust the pH of a 
solution, HCl (diluted from concentrated solution) was used.  Stock solutions were 
prepared by dissolving the polymer in the NaCl solutions and were then allowed to 
equilibrate at room temperature for at least 24 hours prior to further dilution.  Light 
scattering samples for each polymer were prepared at 3-4 concentrations, ranging from 
0.78 to 5.85 g/L.  10 was analyzed at concentrations of 1.46, 2.93, 5.85 g/L (0.1 M NaCl 
aqueous solution) and 1.41, 2.83, and 5.65 g/L (0.5 M NaCl aqueous solution).  At lower 
salt concentrations, 11 was characterized at solution concentrations of 0.78, 1.77, and 
3.53 g/L and 1.45, 2.93, and 5.65 g/L for 0.5 M NaCl.  Due to its high scattering abilities 
at low concentrations, 12 was studied by light scattering at four concentrations: 0.56, 
1.12, 2.23, and 4.46 g/L (0.1 M NaCl) and 0.35, 0.80, 1.60, and 3.20 g/L (0.5 M NaCl). 
3.4.13 Light Scattering Studies:  Static and Dynamic Light Scattering  
For static light scattering experiments, the scattering intensity of a toluene 
solution was first used as the standard.  Sample solutions were directly filtered into pre-
cleaned cuvettes by a syringe equipped with a 0.22 μm-diameter membrane filter.  Static 
light scattering was carried out in the angle range of 35° to 135° with three readings at 
each angle.  Dn/dc measurements were made on a refractometer and used to calculate 
absolute Mw for 10 and 11.  In 0.1 M NaCl, the dn/dc values of 10 and 11 were measured 
as 0.18 and 0.22.  12 aggregated in solution at the concentration range used to determine 
dn/dc, and therefore, its dn/dc in 0.1 M NaCl was estimated as 0.20.   
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In dynamic light scattering studies, the scattering intensity autocorrelation, g2(t), 
was recorded and analyzed by CONTIN algorithm44 to generate a relaxation spectrum 
where a single dominant peak was identified.  Its corresponding relaxation time, 1/t, was 
then plotted against scattering vector square, q2.  The slope of a linear fit of 1/t vs. q2 
yielded the diffusion coefficient of 10 at that specific concentration, D(c).  The diffusion 
coefficient of 10 at zero concentration, D0, was obtained by extrapolating the D(c) vs. c 
curve to c = 0 with the relationship of D(c) = D0(1 + kc) where k is a constant.  To 
determine the hydrodynamic radius Rh, the Stoke-Einstein equation, D0 = kBT/6p?Rh was 
applied where kB is the Boltzmann constant, T represents temperature, and ? is the 
solvent viscosity at T.    
3.5 Future Research   
Additional research in the areas of synthesis and characterization can be 
envisioned to explore the modularity in this system.  Figure 3-6 illustrates additional 
macromonomers that have been synthesized and in some cases polymerized.  Preparing 
these materials and analyzing the correlating solution properties could better explore the 
effects of backbone rigidity, cellular targeting groups, negatively-charged amino acids, 
different cationic amino acid moieties, and graft length.  The final step in the illustrated 
design of these amphiphilic graft copolymers (see Figure 4-2) will be to functionalize the 
PEG end groups with targeting groups such as RGD or folic acid.  Recent work in 
conjunction with Kurt Breitenkamp (Emrick Research Group, Ph.D. 2009) has resulted in 
the preparation of a PEG-RGD-functionalized macromonomer.  Initial attempts at 
copolymerizing this macromonomer with other functionalized monomers were successful 
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and offer promise for incorporating other biologically-relevant, oligopeptide sequences 
into these materials. 
 
Figure 3-6. Oligopeptide-functionalized macromonomers prepared for future 
studies 
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CHAPTER 4 
DNA DELIVERY WITH OLIGOPEPTIDE-FUNCTIONALIZED POLYOLEFINS 
4.1 Nucleic Acid Delivery 
As effective delivery of nucleic acids is at the core of gene-based therapies, 
extensive research has been devoted to determining the effect of structural design on 
transfection.  In polyplexes, DNA binding affinity, endosomal escape, and 
biocompatibility affect the transfection efficiency.  The binding affinity of DNA to the 
transfection agent impacts its interactions with charged serum proteins, salts, anionic 
glycosaminoglycans on cell membrane in the extracellular matrix, and the highly acidic 
endosomal environment within the cell.  Premature dissociation of the polyplex can result 
in reduced cellular entry and/or nucleic acid degradation extracellularly or in the 
endosome.  Heterocyclic groups such as pyrrole and imidazole have been shown to 
strongly bind to DNA due to their ability to specifically hydrogen bond with DNA base 
pairs.1-4  Over the past 30 years, Peter Dervan and co-workers have studied these specific 
interactions between various polyamides based on pyrrole and imidazole groups and the 
minor groove of DNA in an effort to regulate gene expression and offer new therapeutic 
options for cancer and other diseases.5-8  Studies of specific interactions using pyrrole- 
and imidazole-based polyamides with the minor groove of DNA provide insight into 
polymer-DNA interactions and can aid in the development of cationic transfection 
reagents with optimal DNA binding affinity.5-9   
These heterocyclic groups along with secondary amines as found in poly(ethylene 
imine) (PEI) also aid the polyplexes in escape from the endosomal compartments, one of 
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many barriers to nuclear delivery of DNA (Figure 4-1).  After achieving cellular entry 
via pinocytosis, the polyplexes are trapped within endosomal compartments.  The 
delivery vehicle must protect the encapsulated DNA due to the low pH found within 
these organelles as well as facilitate the polyplex’s release into the cytoplasm.  
Incorporating heterocyclic groups and secondary amines into the delivery vehicle buffer 
these endosomal compartments by absorbing protons generated by the endosomal proton 
pump, slowing the acidification of the organelle.  This buffering by the delivery vector 
aids in the polyplex release from the endosome into the cytoplasm.10   
 
Figure 4-1. Cellular barriers for DNA delivery to the nucleus 
 
Adjusting electrostatic interactions between the polymer and DNA can increase 
polyplex stability.  Researchers have demonstrated that the stability of the polyplex, and 
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subsequently the effectiveness of the transfection reagent, vary depending on whether 
lysine, ornithine, histidine, or arginine is the cationic moiety. 11-13  While polylysine-
DNA complexes perform transfection, they do so with very low efficiency relative to 
reagents such as linear and branched polyethyleneimine PEI10 and polyamidoamine 
(PAMAM) dendrimers.14  The recent introduction of branched and dendritic polymers as 
transfection reagents provides insight into the role of macromolecular architecture in 
transfection efficiency and cytotoxicity.10,14,15  A systematic study of linear versus 
branched oligolysine and oligohistidine provides an example of the importance of both 
architecture and functionality in plasmid DNA and siRNA complexation and 
transfection.12  Branched polymers were found to give smaller polyplexes, while greater 
histidine-to-lysine ratios improved protein expression. 
4.2 Oligopeptide-functionalized Polyolefins: System Design for Applications in 
Nucleic Acid Delivery 
Polyolefin-graft-oligopeptide structures were prepared and tested experimentally 
for their utility in nucleic acid delivery.  The concept, illustrated in Figure 4-2, consists 
of an amphiphilic graft copolymer containing a hydrophobic backbone with a 
hydrophilic, charged graft structure.  The simplest amphiphilic graft system consists of a 
homopolymer with cationic grafts, which will enable the study of nucleic acid 
encapsulation resulting from the electrostatic interactions between a cationic polymer and 
negatively-charged plasmid DNA or RNA.  PEG grafts, shown as the second example, 
are dispersed among the cationic grafts to enhance the biocompatibility and  
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Figure 4-2. Design of oligopeptide-functionalized polyolefin materials for 
applications in nucleic acid delivery 
 
protein-resistance of the encapsulated system.  The PEG-corona, expected to form in 
water, will shield the encapsulated nucleic acid from enzymatic degradation in vivo and 
prevent protein adsorption during systemic circulation.  In a more advanced system, the 
PEG grafts incorporated into the copolymer could be end-capped with targeting groups 
that may enable cell-specific delivery.  
Utilization of the graft copolymer structure enables control of numerous system 
parameters that cannot be obtained from linear polymers including: 
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Control over Charge Density – By controlling the length of the cationic amino 
acid grafts, as well as the amount incorporated into the polymer backbone, the degree of 
excess cationic charge can be controlled.  This may prevent the cytotoxicity levels seen in 
PEI, a current standard in polymeric, non-viral delivery systems.10   
Incorporation of Non-immunogenic, Protective Groups – PEG is frequently 
used in biomedical applications due to its biocompatibility and non-immunogenicity.16  
By incorporating PEG grafts, a protective, non-immunogenic outer corona can protect the 
particle exterior of the encapsulated DNA and reduce non-specific interactions and 
protein adsorption during circulation.    
Based upon these design principles, research focused on the preparation of 
hydrolytically stable polyolefins with cationic amino acid grafts via ROMP (Figure 4-3).  
The syntheses and characterization of these materials have been described already in 
Chapter 3.  Nonionic, hydrophilic PEG grafts were incorporated into copolymer 
structures by copolymerization of PEG-functionalized cyclooctene macromonomers.  To 
evaluate the role of architecture in transfection, these amphiphilic graft copolymers were 
compared with linear polylysine (PLL) and commercial transfection reagents with respect 
to protein expression and cell viability following transfection. 
4.3 Results and Discussion 
4.3.1 Materials 
Amphiphilic graft copolymers, consisting of a hydrophobic polycyclooctene 
backbone decorated with pendent oligolysines, were evaluated for their ability to 
facilitate DNA transfection into cells.  ROMP of Boc-protected lysine and PEG-
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substituted cyclooctenes gave polymers 10 and 12 as shown in Figure 4-3.  In polymer 
10, prepared by ROMP of the Boc-protected 5-pentalysine-1-cyclooctene macromonomer 
7, the pentalysine grafts are placed on average at every eighth backbone carbon atom.  
The salt of macromonomer 7 was used in transfection experiments for comparative 
purposes.  Polymer 12 integrates PEG grafts into the structure by copolymerization with a 
PEG1200-substituted cyclooctene macromonomer to reduce the charge density but 
maintain water solubility.  The solid phase peptide synthesis of macromonomer 7 and the 
syntheses of polymers 10 and 12 are described in detail in Chapter 3.19  
 
 
Figure 4-3. Polymers used in polyplex formation and transfection 
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4.3.2 Complexation 
Polymer 10 was first studied for its ability to complex plasmid DNA.  Nuclease-
free aqueous polymer solutions were added to DNA solutions at various N:P ratios (i.e., 
the ratio of protonatable nitrogens in the polymer (N) to DNA phosphates (P)).  Thirty 
minutes after mixing, the solutions were analyzed by agarose gel electrophoresis (0.8 
weight percent with ethidium bromide).  For polymer 10, complete DNA complexation 
was obtained at N:P  > 2 as indicated by the absence of free DNA bands at these ratios as 
shown in Figure 4-4 (representative data for polymer 10e shown).  Dynamic light 
scattering was used to evaluate the hydrodynamic size of the polymer-DNA complexes.  
As shown in Figure 4-4, polyplexes formed by complexation of plasmid DNA and 
polymer 10e are ~80 nm diameter particles with relatively low size distribution.  These 
polyplexes were found to very stable over a 24-hour timeframe in water; no aggregation 
or size change was observed by light scattering. 
 
Figure 4-4. Polyplex characterization:  a) gel electrophoresis and b) dynamic light 
scattering of polymer 10e-DNA complexes 
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4.3.3 Cell Transfection Studies 
Initial transfection experiments were performed with COS-1 cells obtained from 
the Schwartz Research Group (University of Massachusetts Department of Biology).  
Polymers 10 and 12 of the various molecular weights given in Figure 4-3 were 
complexed with the GFP-expressing reporter vector pZsGreen1-N1 and were analyzed 48 
hours post-transfection using a plate reader, fluorescence microscope, and the CellTiter-
Glo? Luminescent cell viability assay.  For comparison, commercial transfection 
reagents jetPEI? (PolyPlus Transfection), Lipofectamine? 2000 (Invitrogen), and 
SuperFect (Qiagen) were also used for COS-1 transfection according to the optimized 
protocols supplied by the manufacturers.   
Cells transfected with polyplexes containing polymers 10b-e at their optimal N:P 
ratios demonstrated substantial protein expression and typically higher cell viability than 
those treated with the commercial reagents (Figure 4-5).  The degree of polymerization 
(DP) of 10 appeared to be important with increasing average DPs of 63, 75, 89, and 206 
(polymers 10b, c, d, and e, respectively) providing better transfection efficiency than the 
lower molecular weight polymer 10a.  It is believed that the stability of the polyplexes 
increases with increasing molecular weight, which results in greater protein expression as 
seen with these materials.  Polyplexes using 10a (DP 30) gave very little protein 
expression as judged by fluorescence microscopy.  In contrast, the highest molecular 
weight derivative polymer 10e (DP 206) showed greater overall gene expression than 
commercial transfection reagents jetPEI?and SuperFect and lower expression than 
Lipofectamine? 2000, while maintaining excellent cell viability.  Increased cytotoxicity 
with higher molecular weight polymer derivatives was not observed as 10e at the optimal 
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N:P for transfection still maintained 99% cell viability in COS-1 cells.  However, 
increased toxicity was observed at higher N:P as in the case of 10b.  In order to obtain 
significant protein expression with this material, an N:P ratio of 4 was required but 
resulted in only 77% cell viability.  Polymers 10b, c, and d also facilitated DNA 
transfection as indicated by protein expression levels but with lower effectiveness than 
10e.   
 
Figure 4-5. Relative fluorescence (left) and cell viability (right) of COS-1 cells 
treated with polymers 10a-e at their optimal N:P ratio for protein expression.  
Fluorescence was measured 48 hours post-transfection (plate reader filters ?exc = 
485 nm, ?em = 520 nm).   
 
When evaluated at comparable N:P ratios as polymer 10, pentalysine 
macromonomer 7 proved unsuitable for transfection (Figure 4-6).  This is in agreement 
with reports by Szoka and coworkers on poor transfection performance with polyplexes 
formed from short oligolysine segments, which require substantially higher N:P ratios to 
effectively complex DNA.11  However, when 7 was polymerized to form amphiphilic 
graft copolymer 10, the resulting material behaved much differently, thus demonstrating 
the benefit of the multidentate interactions inherent to macromolecules and, in this case, 
the graft or comb-like structure designed to facilitate such interactions. 
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Linear PLLs, containing on average 126, 219, and 262 lysine repeat units, were 
also analyzed in COS-1 transfection experiments.  Despite having a similar overall 
number of protonatable nitrogens as polymers 10a-c, which had on average 120, 254, and 
301 protonatable nitrogens per polymer chain, these linear polymers gave low 
transfection efficiency.  The highest molecular weight PLL (DP 262) showed the best 
transfection (Figure 4-6) but was still inferior to polymer 10 derivatives and the 
commercial reagents.  The differing abilities of PLL versus polymer 10 as transfection 
reagents might be attributed to the role of macromolecular architecture (linear versus 
graft structure), as well as the amphiphilic nature of 10 with its hydrophobic backbone 
and hydrophilic oligolysine grafts.  Amphiphilic molecules such as fusogenic peptides are 
known to preferentially segregate to cell membranes and aid in cellular entry. 
The PEG-containing cationic graft copolymers of type 12 were found to be 
inferior transfection vehicles relative to 10 in accord with literature reports on PEGylated 
cationic polymer transfection reagents.20-23  This might be attributed to several factors 
including molecular weight (12 had an average DP of only 35) as well as poorer 
complexation due to a combination of increased steric hindrance and reduced charge 
density.   Also, the presence of the PEG grafts may shield charge on the surface of the 
polyplexes, reducing cellular entry and protein expression.  Although adding the PEG 
segments reduces the transfection in vitro, the incorporation of such groups would be 
advantageous in vivo for systemic delivery applications since PEG chains prevent non-
specific protein adsorption.  Therefore, future efforts should focus on evaluating higher 
molecular weight derivatives of polymer 12 and determining the optimal PEG-to-
pentalysine graft ratio to maximize transfection efficiency for these structures.  
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Figure 4-6. Relative fluorescence (left) and cell viability (right) of COS-1 cells 
treated with polymer 10e, polymer 12, salt of macromonomer 7, linear PLL (DP 
262), and commercial reagents jetPEI? , SuperFect, and Lipofectamine?  2000.  
Fluorescence was measured 48 hours post-transfection (plate reader filters ?exc = 
485 nm, ?em = 520 nm).   
 
With HeLa cells, which are more difficult to transfect and more sensitive to 
toxicity than COS-1 cells, polymer 10e-based polyplexes competed favorably with all 
three commercial reagents.  This is seen qualitatively in the fluorescence microscope 
images of the transfected cells in Figure 4-7.  When polymer 10e served as the 
transfection reagent, little change in the cell morphology was observed, indicating 
minimal alteration to cell growth and minimal cytotoxicity.  This contrasts the 
fluorescence images obtained in experiments with jetPEI?, SuperFect, and 
Lipofectamine? 2000, in which significant morphological alterations and substantial cell 
death was observed.  Figure 4-8 provides a quantitative comparison of 10e-containing 
polyplexes with commercial reagents in terms of GFP expression and cell viability.  Even 
relative to Lipofectamine? 2000, which out-performed all polymer 10 derivatives in the 
COS-1 experiments, 10e proved to be an excellent transfection reagent (relative 
fluorescence units for Lipofectamine? 2000 = 12,000 versus 19,000 for polymer 10e) 
while maintaining high levels of cell viability (17% for Lipofectamine? 2000 versus 
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92% for polymer 10e).  Synthetic polymer delivery vectors are known to be less toxic 
than lipid-based and other systems, but they typically do not reach comparable protein 
expression levels.  However, 10e was found to be extraordinarily effective in facilitating 
DNA delivery while still maintaining excellent cell viability.  The appeal of amphiphilic 
graft copolymer 10e as a transfection reagent can be attributed to its balance of 
transfection efficiency and biocompatibility, a balance which becomes increasingly 
important in vitro for sensitive cell lines as well as in vivo for systemic delivery. 
 
 
Figure 4-7. Fluorescence microscope images (?exc = 467-497 nm, ?em = 516-556 nm) 
of HeLa cells transfected with complexes of pZsGreen1-N1 (GFP-expressing 
plasmid DNA) and various transfection reagents: polymer 10e (N:P 3), jetPEI? , 
Superfect, and Lipofectamine?  2000. 
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Figure 4-8. Relative fluorescence (left) and cell viability (right) of HeLa cells 
transfected with polymer 10e (N:P 3) and commercial reagents jetPEI? , SuperFect, 
and Lipofectamine?  2000.  Fluorescence was measured relative to positive controls 
48 hours post-transfection (plate reader filters ?exc = 485 nm, ?em = 520 nm).  
Deprotected macromonomer 5-pentalysine-1-cyclooctene 7, polymer 12, and 
polylysine were ineffective transfection reagents in HeLa cells (data not shown). 
 
The experiments described indicate that the use of polymer 10e as a DNA 
delivery vector requires attention to multiple factors including the delivery vehicle’s 
molecular weight, amphiphilic nature, and architecture.  Polymer molecular weight is 
known to influence transfection performance as seen for polymers 10a-10e and other 
reported systems.24-27  The high molecular weight of 10e also provides additional 
stabilization to the polyplexes, preventing premature DNA release and subsequent DNA 
degradation.28  Studies by Schaffer, et al. with PLL derivatives (DP 19, 36, and 180) 
demonstrate that intermediate molecular weight polymers are optimal delivery vehicles 
since they balance the need for polyplex stability with the requirement of eventual 
polyplex dissociation.25  In the case of high molecular weight PLL with a DP ~180, the 
DNA was unable to dissociate from the delivery vector, preventing eventual protein 
expression.  However, in our studies with the molecular weight series for polymer 10, a 
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substantial increase in protein expression was observed with the highest molecular weight 
derivative 10e (DP ~206).  This implies that despite the large DP of 10e, which provides 
stability for the polymer-DNA complex, other features of this graft copolymer facilitate 
DNA release from the polyplex once it is within the cell.  Intracellular trafficking studies 
will be reported in the future to better elucidate this structure-property relationship.  
Emrick Group Members Drs. Delphine Chan-Seng and Sangram Parelkar are currently 
conducting these studies. 
Moreover, we note that amphiphilicity is characteristic of naturally-occurring 
fusogenic peptide segments, which are known to aid proteins in cellular entry and 
endosomal escape by membrane interactions.29  Because 10e contains both hydrophobic 
and hydrophilic domains, this polymer vector may enhance cellular entry and endosomal 
escape in a manner similar to fusogenic peptides.  In addition, the hydrophobic backbone 
of 10e may interact with the hydrophobic domains of DNA, further stabilizing the 
polyplex.   
The comb-like architecture of 10e must also be considered when determining the 
structural features which contribute to delivery efficiency.  Pentalysine grafts are present 
on average at every eighth carbon atom, and because of the close proximity of the lysines 
within the graft and along the polymer backbone, it is likely that incomplete protonation 
is achieved.  Studies by Suh et al. with PEI, hydrophobically-modified PEI, and 
polyallylamine show that the protonation of an amine in a multiamine-containing 
compound suppresses additional protonation events.30  They also determined that 
hydrophobic environments make protonation unfavorable.  Therefore, we speculate that 
in 10e the close proximity of the lysine groups, as well as that of the grafts to the 
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hydrophobic backbone, prevent complete protonation of the oligolysine chains at neutral 
pH, thus offering a buffering mechanism that might aid in endosomal escape in vitro.  
4.4 Conclusions and Future Research 
This chapter described a novel and effective transfection reagent based upon an 
amphiphilic, cationic, comb-like polyelectrolyte.  These polyplexes effectively transfect 
COS-1 and HeLa cell lines, while maintaining high cell viability.  These reagents are 
clearly competitive with commercial polymer-, dendrimer-, and lipid-based transfection 
reagents in terms of both protein expression and cell viability, and as such open 
possibilities for new transfection reagent choices among the biomaterials and gene 
delivery communities.  To further elucidate the structure-property relationship of these 
materials, several future experiments could be envisioned with respect to oligolysine graft 
length, molecular weight, and copolymer composition.  While pentalysine derivatives 
were evaluated, expanding the range of oligolysine graft lengths is important as a next set 
of experiments.  While a range of graft copolymer molecular weights were investigated in 
these experiments, it is not yet known whether the optimal molecular weight polymers 
were used.  Additional experiments to determine the ideal molecular weight for DNA 
delivery might lead to such optimization.  Further investigation would also be beneficial 
in the area of copolymer composition.  While initial investigations showed the polymer 2 
offered significantly reduced transfection compared to polymer 1, it is important to 
incorporate PEG grafts for in vivo applications.  Therefore, additional research exploring 
the role of molecular weight as well as copolymer composition (i.e., ratio of 
pentalysine:PEG grafts) on transfection efficiency may provide transfection reagents 
useful in in vivo applications. 
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4.5 Experimental 
4.5.1 Materials  
COS-1 (African green monkey kidney cells, Cercopithecus aethiops) and HeLa 
(human adenocarcinoma epithelial cervical cells) cell lines were purchased from 
American Type Cell Culture (ATCC, Manassas, VA) or donated by the Schwartz 
Research Group (University of Massachusetts, Department of Biology).  Dulbecco’s 
Modified Eagle Medium (DMEM), fetal bovine serum (FBS), penicillin, streptomycin, 
sodium pyruvate, and Lipofectamine? 2000 were purchased from Invitrogen 
Corporation (Carlsbad, CA).  Agarose (molecular biology grade, low-EEO), ethidium 
bromide (1% solution, molecular biology grade), tris-acetate-EDTA (TAE) buffer (10x 
solution, electrophoresis grade), agarose gel-loading dye (6x, contains 15% Ficoll 400, 
molecular biology grade), Costar white-walled 96-well plates, Nalgene PES syringe 
filters (0.2 ?m, 13 mm diameter), and low retention Eppendorf tubes were purchased 
from Thermo Fisher Scientific (Waltham, MA).  Poly-L-lysine hydrobromide was 
obtained from Sigma-Aldrich (Saint Louis, MO).  CellGro Eagle’s Minimum Essential 
Medium, trypsin with EDTA, and non-natural amino acid supplements were purchased 
from Mediatech, Inc. (Herndon, VA).  Gel loading dye was purchased from Biorad 
(Hercules, CA).  jetPEI? was received from PolyPlus Transfection (San Marcos, CA).  
EndoFree Plasmid Maxi Kit and SuperFect Transfection Reagent were obtained from 
Qiagen (Valencia, CA).  DH5? cells were donated by Jeff Kane and Professor Larry 
Schwartz (University of Massachusetts, Department of Biology).  Nuclease-free water 
and CellTiter-Glo? Luminescent Cell Viability Assay were obtained from Promega 
Corporation (Madison, WI).  
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Prior to the encapsulation and cell transfection experiments, the reporter gene 
pZsGreen1-N1, a GFP-expressing plasmid with 4,700 base pairs, was purchased from 
Clontech (Mountain View, CA) and then amplified and purified.  DH5? cells, 
Escherichia coli cells, which had been prepared for transformation, were used as hosts 
for bacterial transformation according to standard molecular biology procedures.31  The 
amplified DNA was isolated and purified with a EndoFree Plasmid Maxi Purification kit.  
UV analysis (Pharmacia Biotech GeneQuant II) was used to determine the concentration 
and purity (260/280 ratio) of the amplified DNA stock solution prepared by bacterial 
transformation. 
4.5.2 Gel Electrophoresis 
Agarose (0.48 g) was added to 1x TAE buffer (60 mL) to prepare a 0.8 weight 
percent agarose gel.  The solution was heated until boiling and apparent dissolution.  
After cooling for five minutes, 3 μL of 1 weight percent ethidium bromide solution was 
added to the agarose solution.  This mixture was poured into a gel cassette containing a 
10-well comb and allowed to set for 30 minutes.  
To prepare the polyplex solutions, 1 μg of DNA was diluted in nuclease-free 
water to obtain a final volume of 10 μL.  Separately, polymer solutions of various 
concentrations were prepared. 10 μL of each polymer solution was added to the DNA 
solution and allowed to equilibrate for 30 minutes.  2 μL of nucleic acid loading buffer 
was mixed with the polyplex solution, and 18 μL of the final solution was loaded onto the 
gel.  The gel was run using a FisherBiotech horizontal minigel (7 x 10 cm) setup and an 
Invitrogen PowerEase500 power supply at 60 volts for 60-90 minutes in 1x TAE buffer.  
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The gel was then imaged with a Spectroline Slimline UV transilluminator equipped with 
a Canon Powershot A620 camera. 
4.5.3 Dynamic Light Scattering 
Polyplexes were prepared in filtered, nuclease-free water in a black-walled 96-
well plate with a total well volume of 100 μl each.  Prior to analyses, the plate was 
centrifuged at 1,000 rotations per minute for 2 minutes to remove excess air bubbles.  
The plate was inserted into a Wyatt DynaPro Plate Reader equipped with a temperature 
control module (set to analyze at 37 °C) and allowed to equilibrate for 10 minutes.  
Acquisition time was set to 60 seconds, and three runs were performed in each well, 
which were averaged together.  The wells were analyzed every six hours over a 24-hour 
period. 
4.5.4 Cell Culturing  
COS-1 and HeLa cells were cultured according to standard protocol32 and utilized 
for cell transfection experiments.   
4.5.5 Cell Transfection 
COS-1 and HeLa cells were cultured according to standard protocol, and low 
passage number cells (less than 20) were used for cell transfection experiments.  COS-1 
and HeLa cells were plated in white-walled 96-well plates at seeding densities of 7 x 103 
cells per well and incubated in 5% CO2 at 37 ºC 24 hours prior to transfection.  After 24 
hours, the cells were 70-80% confluent and were transfected as described below. 
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The polymers and macromonomer (1-2 mg) were weighed into low retention 
Eppendorf tubes, dissolved in nuclease-free water, and sterilized by filtration.  The stock 
solutions were diluted to the appropriate concentrations to enable complexation with 
DNA at various N:P ratios.  DNA solutions (4x solution for each polymer concentration) 
were prepared in a 96-deep well plate.  DNA (1 μg) was added to nuclease-free water (40 
μL).  40 μL of the diluted polymer solutions were added to the DNA solutions and 
allowed to equilibrate for a minimum of 30 minutes.  Prior to transfection, the cells were 
washed with serum-free media.  The polyplexes were diluted with 120 μL serum-free 
media (DMEM for COS-1 cells, MEM for HeLa cells), and 60 μL of the diluted polyplex 
solution was added directly to the cells.  Each condition was repeated in triplicate.  
Commercial reagents PLL, jetPEI?, SuperFect, and Lipofectamine? 2000 were also 
used as transfection reagents according to each manufacturer’s recommended protocol. 
After 4 hours of incubation at 5% CO2 and 37 ºC, 120 μL of serum-containing 
growth media (10% fetal bovine serum, 1% penicillin/streptomycin, 1% sodium 
pyruvate, and 1% non-natural amino acids) was added to each well.  The cell media was 
replaced with 150 μL of fresh serum-containing growth media 24 hours after transfection, 
and the cells were analyzed after 48 hours by fluorescence microscopy (Olympus IX71 
fluorescence inverted microscope equipped with an Olympus DP71 digital camera), by 
plate reader in fluorescence mode (BMG Labtech FLUOstar OPTIMA plate reader) and 
by the CellTiter-Glo? Luminescent Cell Viability Assay.  Transfection data shown in 
Figures 4-5, 4-6, and 4-8 are averaged values obtained over multiple experiments.  In 
each experiment, each unique condition (i.e., different polymer, N:P ratio, etc.) was 
tested in triplicate. 
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4.5.6 Cell Viability Assay 
To determine cell viability 48 hours after transfection, Promega’s CellTiter-Glo? 
Luminescent Cell Viability Assay was performed according to the recommended 
commercial protocol.  The CellTiter-Glo? buffer and substrate were equilibrated to room 
temperature, and the buffer was added to the substrate to form the CellTiter-Glo? 
reagent.  After equilibrating the 96-well plate to room temperature, the cell media was 
replaced with 70 μL of serum-free media, and 70 μL of the mixed CellTiter-Glo? 
reagent was added to each well.  The plate was mixed on an orbital shaker for 2 minutes 
and then allowed to sit for 10-20 minutes.  Luminescence was recorded on a plate reader 
(BMG Labtech FLUOstar OPTIMA plate reader).   The average luminescence values for 
each condition were divided by the average luminescence of the control cells (cells 
treated with media only) to determine the percent cell viability.  As with the transfection 
data, cell viability results shown in Figures 4-5, 4-6, and 4-8 are averaged values 
obtained over multiple experiments. In each experiment, each unique condition (i.e., 
different polymer, N:P ratio, etc.) was tested in triplicate.   
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CHAPTER 5 
FUTURE STUDIES 
5.1 Oligopeptide-functionalized Polyesters 
Click chemistry was successfully used to graft oligopeptide sequences onto 
hydrolytically degradable polyester backbones.  To demonstrate the versatility of this 
technique, the conjugation of various other oligopeptide sequences to the polyester 
backbone could prove interesting.  One proposed study would focus on using click 
chemistry to conjugate cationic oligopeptides to aliphatic polyesters for applications in 
nucleic acid delivery.  While the polyolefin-graft-pentalysine system described in 
Chapters 3-4 offers a hydrolytically stable, robust backbone that can be used to 
encapsulate plasmid DNA, a polyester-graft-pentalysine (or other cationic amino acid) 
generates a polymeric encapsulation system that is degradable.  Azide-functionalized tri- 
and pentalysine and pentaarginine sequences were prepared by solid phase peptide 
synthesis according to the same synthetic techniques previously described for SDGRG.  
Initial experiments were performed to determine if the trilysine-azide sequences could be 
clicked to the polyester backbone without significant degradation.  Several reaction 
conditions were investigated, but additional experiments are necessary to determine 
whether click chemistry is a viable route for introducing cationic functionalities to 
polyesters.  In a similar approach to the polyolefin system described in Chapters 3-4, 
variations in the polymer structure could be explored in future studies for such 
applications including the incorporation of other cationic sequences (lysine versus 
arginine) and PEG groups in conjunction with the peptide grafts. 
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5.2 Oligopeptide-functionalized Polyolefins as Novel Polyelectrolytes 
To further explore these materials as novel polyelectrolytes, future synthetic 
efforts should focus on incorporating structural variations such as negatively-charged 
moieties and increased backbone rigidity.  Along these lines, my synthetic efforts focused 
on varying the cyclic olefin and the charged moiety incorporated into the 
macromonomer.  Norbornene-graft-pentalysine(Boc) was prepared via SPPS by capping 
the N-terminus of the oligopeptide sequence with commercially-available 5-norbornene-
2-carboxylic acid.  Cyclooctene-graft-penta(aspartic acid) was synthesized with and 
without butyl(But)-protecting groups according to a similar procedure as 7 and standard 
Fmoc-SPPS techniques.  The enhanced solubility contributed by the tert-butyl protecting 
groups made the protected derivative easier to purify and polymerize and was used for 
preparing the negatively-charged polyelectrolyte materials.  Upon GPC analysis of 
poly(cyclooctene-graft-penta(aspartic acid)(OBut)), it was found that unlike the 
polymerization of 7, the aspartic acid-containing macromonomer had to be polymerized 
at a concentration of 1 M or above and at room temperature to prevent the formation of 
low molecular weight cyclics.  When the polymerization was carried at elevated 
temperatures (40 °C and above) or at a concentration of 0.5 M, cyclics were observed in 
the GPC chromatogram.  While both the norbornene- and aspartic acid-containing 
macromonomers were synthesized and polymerized, polymerization, deprotection, and 
purification conditions were not optimized, and the resulting polymers’ solution 
properties were not studied.  Future efforts along these lines may provide valuable 
information on the range of polyelectrolytes that can be prepared in this class of 
materials. 
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Additional synthetic modifications can be incorporated to allow the PEG end 
groups to be functionalized with targeting groups such as folate and a RGD oligopeptide 
sequence.  These groups have previously been incorporated into gene delivery systems to 
enable cell-specific interactions and selective cellular entry and can be incorporated as 
PEG end groups.17,18  Initial studies in this area were performed with Kurt Breitenkamp, 
Ph.D. (Emrick Research Group, Ph.D. 2009).  An RGD-containing oligopeptide was 
prepared by SPPS and coupled with cyclooctene-PEG-carboxylic acid on the resin.  The 
resulting compound was cleaved from the resin under mildly acid conditions, isolated, 
and characterized.  Analyses by NMR, GPC, and MALDI support the synthesis of the 
desired cyclooctene-PEG-RGD macromonomer.  Future synthetic efforts should focus on 
copolymerizing this macromonomer with other oligopeptide-functionalized 
macromonomers to create an array of materials with cell-targeting abilities. 
5.3 Oligopeptide-functionalized Polyolefins for Nucleic Acid Delivery 
To further explore the structure-property relationship of oligopeptide-
functionalized polyolefins as nucleic acid delivery vectors, future experiments 
determining the role of oligolysine graft length, molecular weight, copolymer 
composition, the cationic group (e.g., lysine versus arginine), and incorporation of 
histidine groups to aid in endosomal escape may prove interesting.  Ongoing efforts in 
the Emrick Research Group by Drs. Delphine Chan-Seng and Sangram Parelkar are 
focused on comparing the transfection efficiency and cytotoxicity of polycyclooctene 
derivatives containing 3, 4, and 5 lysine moieties per repeat unit as well as the 
determining the optimal molecular weight.   The research described in this thesis showed 
preliminarily the effect of PEG moieties on the resulting copolymer’s transfection 
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properties.  However, additional studies are needed to determine what the optimal 
cationic:PEG ratio is for both in vitro and in vivo applications.   
Since the polyolefin materials were designed to encapsulate various nucleic acids, 
the application of these materials in siRNA delivery should also be explored.  Preliminary 
experiments demonstrated successful siRNA encapsulation and in vitro gene knockdown 
with these oligopeptide-functionalized polyolefin delivery vectors.  Due to the potential 
impact of siRNA therapeutics in treating such diseases as cancer and HIV, additional 
studies are warranted and may provide valuable insight on designing effective siRNA 
delivery vehicles. 
 
. 
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